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  In this project, we focus on developing a method to produce synthetic spider silk 
thin films. Using these films we optimized mechanical properties, lowered cost, and 
improved the environmental impact using different processing methods. Applications for 
spider silk films are broad, ranging from physical protection to biocompatible materials. 
This project was designed to improve mechanical properties and production methods of 
films made from synthetic forms of MaSp1 and MaSp2 from the dragline silk of Nephila 
clavipes. We have increased the mechanical stress (200 MPa) to more than 4 times that of 
similar products with elongations as high as 35%. The films have also been analyzed 
using NMR, XRD, and AFM or SEM showing that the secondary structure in as-poured 
films is mainly alpha-helical and after processing this structure turns to an aligned beta-






Mechanical and Physical Properties of Spider Silk Films Made 
 from Organic and Water-Based Dopes 
Chauncey L. Tucker 
 Spider silk has become a popular material due to its exceptional mechanical and 
biocompatibility properties. The project team has developed methods of producing and 
improving the properties of synthetic spider silk films. Other groups have been able to 
produce similar films having less than impressive mechanical properties using a toxic 
solvent. The spider silk team here at Utah State University has developed a new way of 
processing these films to more than triple their mechanical properties and has created a 
novel form of spider silk films produced from a water-based liquid, making it less 
expensive, more environmentally friendly, and more biocompatible. We have also been 
able to greatly improve the mechanical properties in both forms of production, surpassing 
those previously published.  The physical properties of these films have also been 
examined to understand how these properties are being achieved. 
With the support of USTAR, DOE (SC0004791), and NSF (IIP-1318194) at Utah 
State and the support of AFOSR (FA9550-14-1-0014) and NSF (DMR-1264801) at 
Arizona State we have been able to create a spider silk film that has proven to be stronger 
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Spiders have been around hundreds of millions of years longer than humans, but 
they were not scientifically studied until Aristotle and Democritus observed their web 
building process. Since then, spider silk has been us d by humans in many ways, 
including for fabric, art, and biomedical purposes.1 Spider dragline silk is one of the 
strongest natural fibers known to man (Table 1-1).  
Orb web weavers produce up to six types of silk and o e glue.2 Each of the silks 
produced by orb web weavers is unique to their specific function (Figure 1-1). Dragline 
silk is used as the lifeline for the spider and as structural support in the web. It is called 
dragline silk because it drags behind the spider as it walks along. It is used similar to a 
climbers belay line, gluing it to the substrate on which it crawls to prevent fatal falls.  







Dragline silk 4000 35 400 
Minor Ampullate 
silk 
1000 5 30 
Flagelliform 1000 >200 400 
Tubiliform silk 1000 20 100 
Bombyx mori silk 600 20 60 
Kevlar 49 3600 5 30 
Rubber 50 850 80 
Tendon 150 5 5 







Dragline silk is made up of two different proteins: major ampullate silk protein 1 
(MaSp1)6 and major ampullate silk protein 2 (MaSp2).7 Each protein has a different set 
of repetitive genetic cassettes that create different protein secondary structures and give 
the silk its high strength and high extensibility.2 The secondary structures in spider silk 
are mainly beta-spirals, beta-sheets, and glycine-II-h lices (Figure 1-2). Beta-sheets are 
tight-knit structures that do not allow water penetration and confer mechanical strength to 
the silk. Beta-sheets are mainly produced from the alanine-rich regions, (An) and (GA)n 
in the protein. Beta-turn spirals and glycine-II-helic s, on the other hand, allow 
penetration of water and increase strain, which contributes to the overall toughness of the 
silk. Beta-turn spirals are made due to the GPGGX (X is usually Y or Q) and GPGQQ 
repeat units, and glycine-II-helices are made from the GGX regions.8 






Mechanical properties of spider silk are increased an  fine-tuned by using a 
combination of alignment and beta-sheet content.9,10 Greater alignment and beta-sheet 
content increase stress, but alignment also increases strain.  Alignment is produced by the 
spider pulling the liquid silk proteins from the lumen through an S-shaped duct and out of 
the spinneret.11 Beta-sheets are induced and aligned by the friction of the duct as it 
decreases in diameter.12 Beta sheets are also formed by the removal of water from the 
liquid crystal13 or micelle-like structure.14 
DRAGLINE SILK CHARACTERIZATION 
Natural spider silk has been characterized using nuclear magnetic resonance 
(NMR),15–23 Raman spectroscopy,24,25 X-ray diffraction (XRD),16,26–29 Fourier transform 
infrared spectroscopy (FTIR),30–32 birefringence,33,34 and circular dichroism (CD).35 
Raman uses vibrational rotation of secondary structu e to compare chemical shifts in the 
silk. The only way to quantify secondary structure is through NMR and XRD, although a 
Figure 1-2: Illustrations of secondary structure. (Left) Space filling model of beta-sheet 





group in Canada feels that it can be quantified using Raman and FTIR. The remaining 
methods are useful in comparing changes in secondary structure and alignment, but are 
not able to quantify the percentages of beta-spirals, beta-sheets, and glycine-II-helices. 
Birefringence is an optical property that can be used to compare alignment in solid and 
liquid state. CD is another technique that can be used to measure changes in secondary 
structural shifts in both solid state and liquid state. 
NMR is a technique that measures the resonances of hydrogen and carbon nuclei 
present in the sample. This technique shows the secondary structure present in both a 
solid or liquid state. The main drawback of this technique is that the amino acid 
sequences need to be known in order to assign secondary structural motifs. NMR studies 
have shown that the beta-sheet peaks in the dragline si k stay the same with or without 
hydration, suggesting they provide rigidity and that w ter does not penetrate them (Figure 
1-3).22 Holland et al.22 also showed the beta-spiral and glycine-II-helix peaks drop in a 
hydrated state, suggesting mobility (Figure 1-3). Other work done by Lewis et al. showed 
that the amount of beta-sheet present in dragline silk from Nephila clavipes is 34%. It 
was also found that the percentage of alanine, glycine, and serine correlated to the 
secondary structures present.18 NMR has also played a major role in characterizing a d 
discerning amino acid motifs within the dragline silk8,18 and in discovering new 




XRD is a technique that measures crystallinity and the alignment of beta-sheets in 
spider silk by the scattering of X-rays in a solid state; complimenting NMR readings. 
Using this technique, the alignment and crystallinity of native Nephila clavipes spider 
dragline silk and lyophilized glandular content of the major ampullate gland have been 
measured (Figure 1-4).27 This study shows that the glandular content lacks alignment, 
shown by the lack of meridian reflections (Figure 1-4A). Figure 1-4B reveals that, after 
extrusion, both crystalline and amorphous regions are aligned. Crystallinity can also be 
determined using XRD, also outlined by Sampath et al.,27 determining that dragline silk 
in Nephila clavipes is 28%. 
Figure 1-3: Solid State NMR of dragline silk dry (solid line) and hydrated 





Silkworm Silk Films  
 Silkworm silk has also shown potential for biomedical applications and has long 
been a gold standard for sutures.5 Silk films have been used to grow mouse fibroblasts, 
showing similar attachment and growth as collagen, a commonly used material for 
mammalian cell growth.36 There has also been research done using osteoblast-like cells, 
which proved that the covalent crosslinking integrin recognition sequences (RGD) and 
parathyroid hormone (PTH) induce bone formation on silk films. The project using 
osteoblast-like cells showed that the inclusion of RGD in the silk increased calcification 
and osteocalcin message levels compared to silk without RGD crosslinking.37 This shows 
that silk can not only be used as a coating for medical evices, but also an implantable 
bone graft.  
 Ultrathin silk films have also been made from B. mori silk with a focus on 
increasing mechanical properties. This study used a layer by layer construction of silk 
films by spin coating a water based silk solution onto a sacrificial cellulose acetate layer 
Figure 1-4: XRD images of natural dragline silk. (A) XRD 
image of dehydrated glandular content from major ampullate 




and treating them with water or methanol. The results showed that methanol treatment 
increased both elastic modulus and ultimate strength, but reduced strain (Table 1-2).38 
Although promising, these films are essentially dimensionless and retain only a fraction 
of the tensile strength of natural silk fibers, limiting potential applications. 
 Virgin silkworm silk can elicit a foreign body response (FBR).39 The solution for 
the FBR is the removal of sericin, which decreases its mechanical properties and takes 
time. That being said, purified, degradable silk films have been made that have a similar 
low FBR to collagen or polylactic acid (PLA) films.40 
Table 1-2: Comparison of the mechanical properties of silk, collagen, and other materials 










Spider silk (dragline) fiber 4 4000 35 4 
Recombinant spider 
silk 
Film 0.3 54 1.8 41 
B. mori silk fibroin 
Ultrathin 
films 
6–8 100 0.5-3.0 38 







Collagen film 0.002–0.046 0.9–7.4 24–68 43 
Collagen X-linked film 0.4–0.8 47–72 12–16 43 
Polylactic acid (PLA) sheet 1.2–4.0 28–50 2–6 38,44 
ABS plate 2.1 40 25 44 







Spider Silk Films 
Minimal research has been reported on the mechanical properties of spider silk 
films using recombinant spider silk protein (rSSp).45,46 Some tensile properties have been 
reported, but no studies have focused on improving these properties. It is important to 
note that the proteins used in the studies to date use small proteins (0.06 to 12 KDa), 
which can lead to inferior mechanical properties.47 
Other research has been done to characterize the structure48 and solubility49 of 
synthetic spider silk films before and after a methanol treatment. These studies showed 
through CD and FTIR that treatment with methanol and potassium phosphate induces 
beta-sheet formation, making the films more stable in water and chaotropic agents such 
as urea and guanidine hydrochloride due to stability of he beta-sheet structure. 
Huemmerich et al.49 also showed that silk films can be chemically coupled with organic 
molecules and small proteins. This demonstrates that films hold potential for use in 
biomedical applications.  
Methods have been developed to enhance the mechanical properties of 
recombinant spider silk fibers using a construct similar to this study.50–52 Testing these 
fibers shows an increase of both stress and strain using a “post-spin draw” or stretching in 
an alcohol/water mixture. This post-spin draw has been shown to align secondary 
structure and increase crystallinity, as confirmed by XRD, NMR, and Raman. Stress-
strain graphs of these rSSp fibers seem to follow a similar trend as natural spider silk 
(Figure 1-4). The research shows that the larger the spider silk protein, the better the 
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tensile properties.51 These studies show that it is possible to improve tensile properties of 
recombinant spider silk. 
 
Native silk has been proven to be biocompatible by implanting dragline silk 
subcutaneously in pigs with a complete lack of FBR.53 ecombinant spider silk films are 
able to support attachment and proliferation of a variety of cells, including fibroblasts,54 
osteoblasts,55 and human bone marrow derived mesenchymal stem cells.56 These studies 
not only show that spider silk films are biocompatible, but also show that, in the case of 
mesenchymal cell growth, spider silk is more effective han tissue culture plastic. When 
growing mouse fibroblasts, it was shown that spider silk with cross-linked RGD helps to 
improve biocompatibility, as evidenced by improved adhesion and proliferation 
compared to spider silk without RGD cross-linking.54  
Figure 1-5: Stress-strain curve of synthetic spider silk fibers. Bioinspired fibers 
using two constructs and mixtures of the two. Shaded ar a corresponds to the range 
on tensile properties by natural dragline silk from Argiope trifaciata spider.50 
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One of the advantages of using films over fibers is that films do not need to be 
woven together after processing to make functional products, which dramatically reduces 
the cost of production. Films have different applications than fibers, due to their ability to 
coat materials and mold into different shapes. These applications include coatings for 
medical devices,57,58 skin implants,59 drug delivery, and cellular scaffolds.36,37,60 
Improving and understanding mechanical properties of films will provide a base for 
further research that tailors films to different applications.  
The goals of this project were to (i) optimize energy to break in processed spider 
silk films, (ii) characterize the properties of the films to understand chemical shifts and 
mechanical properties, (iii) reduce the cost of production with new dope formulations, 
(iv) reduce the environmental impact with the exclusion of HFIP, and (v) increase 












MECHANICAL PROPERTIES OF RECOMBINANT SPIDER SILK FILMS I 
(ORGANIC SOLVENTS)* 
*Co-Authors include: Justin A. Jones, Heidi N. Bringhurst, Cameron G. Copeland, J. 
Bennett Addison, Warner S. Weber, Qiushi Mou, and Jeffery L. Yarger 
ABSTRACT  
Spider silk has exceptional mechanical and biocompatibility properties. Our goal 
in this study was optimization of the mechanical properties of synthetic spider silk thin 
films made from synthetic forms of MaSp1 and MaSp2 which compose the dragline silk 
of Nephila clavipes. We increased the mechanical stress in MaSp1 filmssolubilized with 
HFIP with the addition of glutaraldehyde, then subjecting them to a post-pour stretch of 
2.75X in 80%/20% methanol/ water, resulting in stres as high as 190 MPa and 
elongations up to 28%, which is 4 times higher than no -GTA, non-stretched controls. 
Films were analyzed using NMR, XRD, and Raman, which showed that the secondary 
structure in the raw protein powder is in a beta-sheet conformation, but after 
solubilization and film formation as-poured films are mainly in an alpha-helical 
conformation. After a post-pour stretch of 2.5X in 80%/20% methanol/ water bath both 
MaSp1 and 2 protein structures revert back to aligned beta-sheets.  
INTRODUCTION 
Spider silk fibers have remarkable properties that could allow it to function in a 
variety of applications including textiles, biomedical, and manufacturing 
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applications.4,8,21,36,37,47,55,61–63 Of particular interest is dragline silk with both a high 
strength and elongation.4 In recent years, producing spider silks synthetically has become 
a major point of emphasis because spiders cannot be farm d as they are both territorial 
and cannibalistic. Efforts to produce recombinant spider silk proteins (rSSP) have 
focused on the production of fibers47,61,62,64,65 while comparably little effort has been 
expended investigating alternative forms such as films, hydrogels, lyogels, and adhesives.   
Dragline silk is used as the lifeline for the spider and as structural support in the 
web and is one of the strongest natural fibers known to man.4 Dragline silk is made up of 
two different proteins: Major ampullate silk protein 1 (MaSp1) and Major ampullate silk 
protein 2 (MaSp2), each with a molecular mass of arund 300 kDa.66,67 Native dragline 
silk is spun starting in the gland as a viscous water based liquid crystal13,68 in a micelle-
like structure14 in a liquid dope. Beta-sheets are induced and aligned by the friction of the 
duct as it decreases in diameter.12 Beta-sheets are also formed by the removal of water 
from the liquid crystal13 or micelle-like structure.14 
Nuclear magnetic resonance (NMR),21,15–20,22,23 Raman spectroscopy,24,25 and X-
ray diffraction (XRD),16,26–29 show that secondary structures in spider dragline silk are 
mainly beta-spirals, beta-sheets, and glycine-II-helices. Beta-sheets confer mechanical 
strength to the silk and do not allow water penetration.23 Beta-sheets are mainly produced 
from the alanine-rich regions, (An) and (GA)n in the protein. Beta-turn spirals are made 
from the GPGXX (X is usually Y or Q) and GPGQQ repeat units, and glycine-II-helices 
are produced from the GGX regions.8 These glycine-rich peptide regions allow 




Synthetic spider silk fibers have been spun using rSSp to mimic natural spider silk 
properties.47,61,62,64,65 It has been shown that in order to produce a strong fiber the larger 
the protein size the better the strength.47 Dope formulation is also an issue, as the best 
solvent found to solubilize proteins is 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP). The 
actual spinning process is also difficult to mimic, as current systems have a syringe and 
push the liquid dope out of small diameter (0.005” to 0.01” ID) PEEK tubing,64 rather 
than the native pulling action. The secondary structures in the fibers need to be induced 
and then aligned, done by using a combination of a coagulation bath, liquid baths, and 
stretching.47,61,62,64 The fibers then have to be woven or braided together to form a 
product. 
Minimal research has been done on rSSp films. Recombinant spider silk film 
formulations have recently been found to be a promising biological material for their 
ability to attach and cause proliferation of fibroblast cells.36  It was also found that the 
protein can be both genetically modified and chemically functionalized with cell adhesive 
peptides.54 This allows for further applications in the medical industry. Silkworm and 
spider silk films have also been studied for their biomedical applications using 
fibroblasts, osteoblast-like cells, and skin cells36,37,55,63,69,70 all showing as much 
attachment as traditionally used materials. The chemical stability of rSSp has also been 
shown to be controllable using alcohol treatments71,72 and amino acid composition.73,74 
The mechanical properties of spider silk films have be n reported, but no reports have 
improved on the initial properties.41,75 Of the studies done on silkworm silk films only 
one was done to improve or to tailor the mechanical properties, which can make it a 
candidate for a biological material and scaffolds for tissue engineering.38  
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An advantage of using films over fibers is that films do not need to be woven 
together after processing to make functional products, which dramatically reduces the 
cost of production. The production of a film can be as simple as formulating a dope and 
pouring it. Dopes can also be modified by a change i  formulation to have increased cell 
attachment,54,56 drug release,41 and mechanical properties.41,75 Film applications include 
coatings for medical devices,57,58 skin grafts,38,59,63 drug delivery,41 and cellular 
scaffolds.36,37,60 Improving and understanding the mechanical properties of films will 
provide a base for further research that tailors films to specific applications.  
The proteins in this study are rSSp’s produced in the milk of transgenic goats, 
derived from the N. clavipes major ampullate silk proteins MaSp1 and MaSp2, which 
combine to form the dragline fiber. The films are fabricated using a liquid dope, with 
primarily HFIP used as a solvent, cast into a mold t  produce films 10-30 µm thick. The 
protein concentration and solvent composition are vried to increase mechanical 
properties. Films are post-casting processed using a combination of vapor treatments, 
liquid treatments, and stretching to increase stres, strain, and energy to break. To our 
knowledge this is the first reported rSSp film production method tailoring mechanical 
properties.  Improving the mechanical properties of rSSP films will widen potential 
applications for such materials. 
MATERIALS AND METHODS 
MaSp1 and MaSp2 Purification 
Milk from transgenic goats is first collected and frozen, then 6-8 L of milk is 
thawed, and defatted using a Milky cream separator (FJ60 by Clair®). The defatted milk 
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is brought to a pH of 9 using 0.1M arginine-HCl with the milk solution at 4˚ C for 30 min 
while stirring. The solution is then clarified and concentrated using tangential flow 
filtration (TFF) with 750 kD and 50 kD membrane filters with the 750 KDa permeate 
flowing into the 50 kD with the permeate flowing back into the 750 kD.76 The retentate 
from each 750 kD column and 50 kD column are recycled through their respective 
columns. The rSSP’s are precipitated from the 50 kD column retentate. Solid ammonium 
sulfate is added slowly to a concentration of 1.2M while stirring to precipitate the rSSP 
from the remaining milk proteins. The solution is allowed to precipitate overnight and 
centrifuged at 15970g for 60 min.  The supernatant is removed and the pellet is washed 
multiple times using dH2O followed by centrifugation at 15970g for 60 min util the 
conductivity of the supernatant is below 20 mS/cm. rSSP pellets are then lyophilized to 
remove all water and tested for purity via Western blot analysis using αM5 as a primary 
antibody and AP conjugated donkey anti-rabbit as a secondary antibody (Santa Cruz 
Biotechnology). 
PDMS Mold   
 The mold to form the films is made from a polydimethylsiloxane (PDMS) 
solution of 20:1 base to initiator and pouring it into a medium sized petri dish to 0.2 mm 
thick. The petri dish and solution is then put into a vacuum chamber for 20 minutes to 
remove all bubbles. The solution is then set overnight in an oven at 70 ºC to harden. The 
solidified PDMS is removed and cut using a forceps and a razorblade to four 30 x 7 mm 
strips keeping the PDMS clean of particulates. The PDMS strips are placed in a new petri 
dish side by side, avoiding touching, and a solution of 5:1 base to initiator PDMS 
16 
 
solution is poured over the strips, with the solutin at least 1 mm above the strip. The 
petri dish with the PDMS solution is placed into a vacuum chamber and the bubbles 
removed for 20 minutes, and then set overnight in an oven at 70 ºC to solidify. The 
PDMS is removed from petri dish and the 20:1 strips are carefully removed using forceps 
and a razorblade so as to not damage the 5:1 mold. The mold is then thoroughly cleaned 
using soap and water followed by Isopropanol (IPA).  
Dope preparation and film formation 
A standard dope contains 5% protein powder (w/v) dissolved in HFIP by 
overnight rotary agitation and centrifuged for 2 min at 18000g to remove any particulate 
matter remaining. The dope is carefully pipetted (200 µL) out of the vial and poured into 
a pre-made PDMS mold described above, in a chemical hood (Thermo Scientific 
Hamilton Concept) with the sash opened as far as pos ible to slow air flow over the films 
and decrease drying time. After 2 hours the films are dry, and starting to peal themselves 
out of the wells. The films are removed using forceps and the edges cut, producing a flat 
film.   
Post-Pour Treatments 
Vapor treatment 
Films were first cut using a razor blade to 3.5 x 15 mm strips and weighed to 
determine thickness (Equation 1). The cut films were then glued to a c-card (Figure 2-S1 
at end of chapter), as previously described. The films were vapor treated using different 
ratios of Isopropanol (IPA), water, and methanol (MeOH) at room temperature. Vapor 
treatment consists of putting the films into a small petri dish which is then nested into a 
17 
 
larger petri dish with 5 mL of the treatment solution in the bottom; the lid is placed on the 
larger petri dish to contain vapors. Cold treatment is simply putting the films into a closed 
petri dish and putting them into a refrigerator. All treatments lasted for 30 minutes. 
Stretching 
To stretch the films a custom made stretching device (Figure 2-1) was created 
using two, 3” x 3” x 1/4” inch (B and C) and two 3 1/8” x 3” x 1/2” (A and D) sheets of 
polycarbonate secured by two 1/2” dowels 3/4” from the bottom and 1/2" from the both 
sides and a 1/4 inch fiberglass dowel 1 3/4” from the bottom and in the center. All dowels 
are glued to sheets A, C, and D. A 1/8 inch all thread rod is also placed through all sheets 
except for the moving piece (B) which is threaded for piece B, A nut is also added flush 
with part D on both sides in order to make part D move. An extra nut is also placed at the 




Figure 2-1: Diagram of the stretching 
apparatus used to glue as-poured films (across 
B and C), submerge the films in a stretch bath, 
and stretch the films by turning the all thread 
(E) clockwise. 





Untreated films (dried for a 24 h) were first cut using a flat edged razor blade on a 
cutting board along the edges to ensure consistent thickness. The films are then cut in half 
lengthwise and glued to the custom made stretching apparatus described above (Figure 2-
1). The stretching apparatus is inverted with the top of pieces B and C in a defined 
mixture of alcohol and/or water ,with percentages measured by volume, for a period of 30 
sec, it is then rotated right side up and the film strips immediately stretched by turning the 
all thread clockwise (part E in Figure 2-1). With an initial film length of 8.5 mm the final 
length was determined by multiplying the initial length by the stretch ratio, for example a 
3X stretch has a final length of 25.5 mm.  
Mechanical Testing 
The films, post-stretching, are cut to a specific length and width to weigh them 
and calculate the thickness using a density for dry spider silk fiber of 1.23 g/cm3.77–79 The 
films are then mounted on a plastic C-card (Figure 2-S1) length wise using Loctite super 
glue (liquid) across an 8 mm gap.80  After mounting, the C-card is loaded on an MTS 
Synergie 100 (50N load cell) by clamping the top and bottom of the film and card into 
the instrument with alligator clips and then cutting the side of the c-card (indicated by the 
dotted line in Fig. 2-2) so the only thing being tested is the film.65 The film is then tested 
to breaking at a stretch rate of 5 mm/min, with data collection at 30 Hz to measure the 
film’s load in order to calculate stress, strain and e ergy to break using MTS’s 
TestWorks 4, 2001. 
Thickness cm  
.    !"#$ !
       (1) 
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Nuclear Magnetic Resonance (NMR) 
All 13C solid-state NMR data were collected on a 400 MHz Varian Wide-Bore 
instrument using a 1.6 mm solids triple resonance probe.  Samples were packed into a 1.6 
mm zirconia rotor and spun at the magic angle at 30 kHz MAS.  1H - 13C cross 
polarization conditions were calibrated using 13C-enriched Glycine, and the CP condition 
was met by using a ramped (~15%) 1H spin-lock pulse centered at 130 kHz RF field 
strength, and a square spin-lock pulse on the 13C channel matched to the -1 spinning side 
bands of the Hartmann Hahn profile.  All spectrum were collected using a 50 kHz 
spectral width, 8 ms acquisition time, 12288 scan averages, a 1 ms CP contact time, a 5 
second relaxation time, and 150 kHz two-pulse-phase-modulated (TPPM) decoupling 
was applied on the 1H channel during acquisition.  50 Hz exponential line broadening 
was applied to each spectra prior to Fourier transform.  The 13C chemical shifts are 
referenced externally to TMS at 0 ppm by setting the downfield resonance of adamantane 
to 38.56 ppm. 
Raman  
 The films were analyzed using a home built Raman system. Films were placed 
bridging the space between two parallel glass slide to eliminate background and excited 
with a 150 mW 532 nm Coherent Sapphire SF laser focused onto the sample with a 50x 
magnification APO plan Mitutoyo 2.0 cm working-distance objective. The laser power 
was controlled using neutral density filters to make the power at the sample 28 mW 
which optimized the balance between signal-to-noise and sample damage. The Raman 
signal was collected in back scattering geometry.The laser wavelength was discriminated 
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from the Raman signal using an Ondax SureBlock(TM) ultra-narrow-band notch filter. 
An Acton Research SpectraPro 300i monochromator with a 1200 g/mm grating coupled 
to a PI liquid nitrogen cooled CCD detector was used to collect Raman signal for 5 
acquisitions of 60 seconds each at a resolution of 1.5 cm-1.  Cyclohexane and 
acetaminophen were used as calibrants. 
X-Ray Diffraction 
 Samples were taken to the Advanced Photon Source located at Argonne National 
Laboratory, Argonne IL, USA and wide-angle x-ray fiber diffraction was performed on 
the BioCars 14BM-C beamline using a beam energy of 12.6 keV and approximate size of 
130 x 340 µm.  Films were mounted and were placed at a distance of 300mm from the 
ADSC Quantum-315 9-panel CCD array detector. Stretched films were placed with the 
stretched axis parallel to the beamstop and mounted to a goniometer. The exposure time 
was 60 seconds for each of ten images averaged for each sample. For each sample, 5 
background images were taken following each sample with the same parameters and 
calibrated with CeO2. Images were then processed using Fit2D software and Matlab. 
Statistical Analysis 
 All statistical analyses on tensile properties were done using a one-tailed t-test 
assuming equal variance with a null hypothesis that the sample means are equal. A p-





RESULTS AND DISCUSSION 
To create the films, a suitable substrate was investigated to create a mold for film 
formation. Glass, aluminum, Teflon, and PDMS were all tested as substrates for film 
formation and removal. The substrate that proved to be the best was PDMS due largely to 
its hydrophobicity. The films could be peeled off easily after drying, which reduced 
mechanical damage. PDMS also provides a smooth surface free of machine marks.  
 The next important step was to establish the best pouring and drying method. An 
important factor in the pouring method was dope comp sition. It was found that 5% 
protein dopes were easy to solubilize, pour, and provided a thickness of 20 - 30 µm. To 
optimize the drying method, atomic force microscopy (AFM) was used to analyze surface 
topography. In initial work during drying, pores were created throughout the film. The 
pores are thought to occur due to the HFIP evaporating so quickly that it leaves holes in 
the films as it bubbles out. Because of this, it was thought that a slower rate of 
evaporation would optimize film production. A variety of drying techniques were 
investigated (Table 2-1) in order to achieve this. Pore tomography was measured using 
atomic force microscopy (AFM) in tapping mode (Figure 2-S1 at end of chapter).  The 
drying method that was chosen to use throughout this study is drying in a chemical hood 
with the sash opened as far as possible to slow the air movement.  It was also assumed 
that because the problem of pore formation arises from HFIP evaporation, this method 





Table 2-1. Comparison of pore sizes between pouring methods 
measure by AFM 








MaSp2 Open sash 6.8 293 4.56 
MaSp2 Refrigerated 7.4 625 >80 
MaSp2 Turbulent Air 0.6 6200 230 
MaSp2 Vacuum 
Chamber 
11.4 449 5.15 
 
After optimizing the film production process, preliminary testing of un-processed 
films using MaSp1, MaSp2, varying ratios of MaSp1 and 2, and different dope solvent 
formulations including formic acid (FA) and glutaraldehyde (GTA) (Table 2-2) was 
performed. Dopes with formic acid follow the procedure of a standard dope with the 
exception that formic acid, 88%, is added to the dope before centrifugation and dopes 
with GTA have the exception that after centrifugation the dope is removed carefully from 
the vial and put into another vial and GTA (1 µL/mL) is added by pipette and the vial 
gently rotated by hand before pouring.  
All untreated films mechanical properties were mechanically tested the same day 
they were poured. Beta-sheet formation was measured on MaSp1 and MaSp2 films with 
GTA using XRD over a week after pouring, which showed little difference between the 
two (Figure 2-2A and 2-S2). It is also evident through mechanical testing that formic acid 
increases stress with the highest being MaSp1 with formic acid. The addition of GTA 
increased strain, leading to a tripling of the energy to break for pre-processed films. 
MaSp1 films with formic acid were also tested after conducting a vapor treatment which 
involved placing the films in a small petri dish, which was placed in a larger petri dish 
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with the treatment liquid and the lid placed over the large petri dish. The vapor treatment 
time is 30 minutes and the films were tested for mechanical properties the following day 
(Supplementary Information Table 2-S1). The IPA vapor treated films produced the 
highest average stress 79.6, but the lowest average strain 0.03, suggesting an increase in 
beta-sheet content. 
Table 2-2. Preliminary mechanical testing results with average nd standard deviation 
with a 95% confidence interval from untreated MaSp1 and MaSp2 films with different 












MaSp1 2.04 ± 0.81 42.12 ± 8.52 0.068 ± 0.02 
MaSp1 w/ GTA 8.42 ± 9.67 32.97 ± 14 0.621 ± 0.77 
MaSp1 w/ 20% FA 2.87 ± 1.09 50.4 ± 4.75 0.076 ± 0.03 
MaSp2 0.64 ± 0.28 29.52 ± 2.49 0.036 ± 0.01 
MaSp2 w/ 20% FA 0.66 ± 0.35 44.6 ± 6.34 0.028 ± 0.01 
20/80 MaSp1/MaSp2 w/ 20% FA 1.3 ± 0.74 36.56 ± 11.09 .051 ± 0.02 
50/50 MaSp1/MaSp2 w/ 20% FA 0.47 ± 0.42 34.28 ± 12.1 0.024 ± 0.01 
80/20 MaSp1/MaSp2 w/ 20% FA 3.73 ± 1.88 45.21 ± 12.65 0.13 ± 0.08 
 
Stretching Films 
Stretching spider silk fibers has been shown to increase both stress and 
strain47,61,62,64 by aligning secondary structure. In this study a similar technique is used to 
improve mechanical properties.  Initially, the films were stretched by hand, but this 
method of stretching was both difficult and unreliable. A stretching apparatus custom 
made in our laboratory (Figure 2-1) was created to establish an easy method to create a 
consistent, uniform stretch. This apparatus made it possible to obtain results that were 





Figure 2-2: 2D WAXD images of MaSp1 spider silk films as-poured (A) 
and post-pour stretched 2.5 times its original length following an 80/20 
Methanol/Water bath (B). The double arrow in (A) and (B) represents the 
direction of film stretch alignment which is parallel to the beamstop shadow 
(blue). Shown in (C) is the 1D azimuthal intensity profile of radially 
integrated reflections at 4.2 Å-1 of (B) with Gaussian fits. Full 1D radial 
intensity azimuthally integrated profile of (B) with beamstop shadow and 







important to note formic acid impaired the post-pour stretching of the spider silk films 
after the stretch bath and therefore was not included in the dopes for stretched films.  It is 
hypothesized that formic acid increases beta-sheet content preventing sufficient 
penetration of water or alcohols. 
  The best stretching results were established by using a 2-3X stretch and testing 
different ratios of IPA, methanol (MeOH), and water in the bath. The results of these 
experiments (Table 2-3 and Figure 2-3) show that the films stretched in the 80/20 
MeOH/water bath performed the best with an average energy to break more than twice 
that of the other films.  
Table 2-3. Mechanical properties of films with average and standard deviations with 95% 
confidence interval after post-pour stretch using set ratios of IPA, MeOH, and water. 
Dope Composition + Stretch Solutions 
with Stretch Ratio  
Average Energy to 








MaSp1 with GTA + MeOH 2 X 18.65 ± 8.95 109.61 ± 8.69 0.204 ± 0.1 
MaSp1 with GTA + 50/50  IPA/water 
3 X 
23.14 ± 5.7 102.91 ± 12.44 0.258 ± 0.06 
MaSp1 with GTA + 80/20 
MeOH/water 2 X 
25.8 ± 9.61 112.69 ± 15.03 0.257 ± 0.08 
MaSp1 with GTA + 80/20 
MeOH/water 2.75 X 
42.1 ± 9.76 189.39 ± 17.25 0.281 ± 0.05 
MaSp1 + 50/50 MeOH/IPA 2 X 23.58 ± 12.31 75.59 ± 17.66 0.334 ± 0.12 






To examine the stretch factor on films, the 80/20 MeOH/water solution was used 
to determine mechanical changes in a range of stretching ratios (Figure 2-4). As the 
stretch factor increased, stress increased up to a maximum of 210 MPa, while strain 
decreased by at least 25% with each incremental step. With an increased stretch factor the 
stress-strain graph changes, the yield strength increases, and the slope following that 
point increases. The films with 2.5 X stretch show a yield behavior with slight strain 
hardening, and the films with 2.75 and 3.25X stretch factor show strain hardening and no 
yielding directly after the initial jump in stress. This shows that the films can be tailored 
to different applications, with only a change in stretch factor.  
Figure 2-3: Bar graphs for stretched films showing average strs , strain, and energy to 





Previous research on mechanical properties of gelatin films has revealed that 
GTA can increase crosslinking of protein, which increases mechanical properties, 
primarily stress.43,81 Preliminary testing showed that the spider silk films with GTA had 
higher strain but lower stress (Table 2-2). After this discovery, GTA was used in the dope 
for all post-pour stretched films. This produced an increase in both stress and strain and 
also increased consistency (Table 2-3). Testing showed that the GTA only helps after the 
films dry for a full day prior to post-pour treatment. 
  After establishing processing procedures, MaSp2 dopes were also made, as well 
as MaSp2/MaSp1 combination dopes. The resulting films were processed using 80/20 
MeOH/Water and 2.5X stretch with GTA in the dope (Figure 2-5). There was no 
significant difference in stress or strain between the films that contained mixed proteins, 
















80/20 Methanol/Water Increasing Stretch
Figure 2-4: Select stress-strain graphs of MaSp1 samples 
with GTA films to illustrate the difference in stress and 
strain with a given stretch factor using 80/20 MeOH/Water 
as a stretch bath. With the following legend: 2.5X stretch 




protein films had the highest stress (182 MPa) and the MaSp2 protein films the highest 
strain (33%).  
 
 
 MaSp1 and MaSp2 films processed using 80/20 MeOH/water stretch bath, and 
stretched to 2.5 X, were also characterized using XRD, the images show an increase in 
beta-sheet content and alignment (Figure 2-2B and 2-S2B at end of chapter) from the 
films that were not stretched (Figure 2-2A and 2-S3A at end of chapter). Wide-angle X-
ray diffraction of the films yields nano-crystalline Bragg reflections and an amorphous 
halo. The XRD pattern shows that the crystalline structure within the stretched films is 
also aligned parallel to the stretch direction, with calculated Herman's orientation factors, 















MaSp1 vs MaSp2 Comparisons
Figure 2-5: Stress-strain graphs comparing films 
composed of MaSp1, MaSp2, or a mixture of 
MaSp1/MaSp2; all samples received the same 
post-pour treatment. With the following legend: 
MaSp1 (dashed line), 75/25 MaSp1/MaSp2 
(solid line), 50/50 MaSp1/MaSp2 (single dotted 
dashed line), 25/75 MaSp1/MaSp2 (dashed line) 
and MaSp2 (double dotted dashed line). 
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the equatorial reflections where  %& is calculated (equation 2) from the angle, φ, between 
the longest axis and the fiber axis. 
%&  &'(
)*+
    (2) 
Radial integration along the equator gives the peak positions and widths of the 
(200) and (120) reflections which are used to calcul te the a and b axes of the unit cell 
and nanocrystal dimensions. Along the meridian, the (002) reflection gives the 
information concerning of the c-axis of the unit cell. Spider silk proteins have been 
shown to form orthorhombic unit cells and the unit cell dimensions calculated from the 
peak positions of wide angle X-ray diffraction WAXD reflections are calculated from 









&)    (3) 
Radial integration along the equator (Figure 2-2C) and meridian were fit to 
Gaussian peaks and the peak positions were converted to inverse space following Bragg’s 
Law to calculate unit cell dimensions. Average crystallite size in each dimension is 
calculated from the radial broadening in 2θ space using Scherrer’s formula and these 
results are shown in Table 2-4.83 
The crystallinity, xc, can be estimated by radial integration of the equatorial 
reflections which are the crystalline peaks due to Bragg diffraction relative to the full 
integrated peak area yielding 47.3% and 48.2% crystallini y for MaSp1 and MaSp2 
respectively.84 
3&  456789.67, 7:;.6'9<.2 97=27&6<'5(>;22 9.,<.2 <56789.6<'5     (4) 
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Table 2-4: Unit cell and crystallite dimensions calculated from 
WAXD. 
Material Unit cell (Å) Crystallite (nm) 
MaSp1 post-stretch 
film 
6.90 x 9.73 x 
10.50 




6.75 x 9.87 x 
10.03 
0.74 x 3.11 x 24.7 
 
13C solid-state NMR data collected on MaSp1 and MaSp2 films is presented in 
Figure 2-6 and the information is used to track molecu ar-level structural changes during 
the course of film production.  Chemical shifts for relevant amino acids alanine, glycine, 
serine, proline and glutamine are indicated with dotted lines, and red arrows are used to 
emphasize changes to silk secondary structure during film production.  For both MaSp1 
and MaSp2 samples, the film progress is tracked from top to bottom; purified protein 
powder (2-6A, 2-6D) is solubilized in HFIP and casted as a film in PDMS wells (2-6B, 2-
6E).  As-poured films are then stretched 2.5X in a bath of 80/20 MeOH/water (2-6C, 2-
6F).  In both cases one notices that initially, alanine-rich regions within the purified 
MaSp1 or MaSp2 protein powders exist primarily in a beta-sheet conformation.  This is 
expected; the purified protein is not water soluble, pr sumably because of the polyalanine 
beta-sheet aggregates.  HFIP is commonly used to solubilize large silk-like proteins 
because of its ability to disrupt insoluble beta-sheets and stabilize alpha-helical secondary 
structures.85,86  Our NMR data indeed shows a dramatic transformation of polyalanine 
regions into an alpha-helical conformation for films cast from HFIP silk dopes.  This is 
evident in the characteristic downfield and upfield shifts of Ala Cα and Ala Cβ 
resonances, respectively, as illustrated by the outward pointing red arrows.  While the 
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majority of volatile HFIP solvent is removed via evaporation, the 13C resonance near 70 
ppm is attributed to residual HFIP that remains bound to the silk protein backbone.  NMR 
data shows a transformation of polyalanine regions from helical back to beta-sheet 
structures when as-poured films are stretched in 80/20 MeOH/water; again this is 
highlighted by inward-pointing red arrows.  In the case of the MaSp2 sample where 
serine, which is often contiguous to the polyalanine regions, is well represented, we 
notice a similar trend; HFIP solubilization encourages a helical structure, but a significant 
fraction of serine residues are driven into a beta-sheet conformation upon stretching.  
This structural transformation is also correlated with the loss of the HFIP resonance near 
70 ppm, indicating that the helical-stabilizing organic solvent is driven away from the silk 
protein during the stretching procedure.  NMR data therefore strongly suggests that 
alanine-rich repeat motifs from both MaSp1 and MaSp2 films form beta-sheet 
nanocrystalline structures. This is in line with WAXD results that indicate both beta-sheet 





Multidimensional NMR would be necessary to extract precise chemical shifts for 
proline and glutamine residues, thus a complete chara terization of GPGXX motifs in 
MaSp2 films is not possible.  However, the collective chemical shifts of Pro Cγ / Glu Cβ 
and Pro Cβ / Glu Cγ at 25 and 30 ppm, respectively, are very consistent with natural 
dragline spider silk samples.  NMR experiments on the MaSp2-rich Argiope aurantia 
spider dragline silk by Creager et al find that GPGXX motifs from MaSp2 protein exist in 
elastin-like type II beta-turn or beta-spiral strucures.87  It is therefore likely that MaSp2 
films share this structure.  The resonance at 25 ppm from GPGXX regions also shows a 
narrowed line shape in stretched MaSp2 films as compared to the protein powder and the 
as-poured film.  This observation suggests that stre ched films contain a more uniform 
Figure 2-6: 1H - 13C CP-MAS spectra of MaSp1 films (left) and MaSp2 films (right) in various 
stages of production.  Some resonances from dominant ami o acids glycine, alanine, serine, 
proline and glutamine are highlighted with dotted lines, and protein secondary structure is 
indicated when appropriate.  Red arrows are used to mphasize structural changes occurring 
during production.  From top to bottom:  Purified protein powder (A, D), as-poured films from 
solubilized protein in HFIP (B, E), and films stretched in 80/20 MeOH/water (C, F).  
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distribution of chemical shift and therefore less heterogeneity in the distribution of 
molecular environments.  This is consistent with XRD data that show an increase in 
molecular orientation upon stretching. It is concluded that the act of film stretching in 
alcohol/water baths not only drives out HFIP and induces beta-sheet formation of 
alanine-rich regions, but also improves alignment and regularity of both beta-sheet 
nanocrystals and elastin-like GPGXX structures. 
Raman spectroscopy characterization was also done on the spider silk powder, 
untreated films and post-pour stretched films (Figure 2-7). This illustrates the secondary 
structure changes taking place as the MaSp1 and MaSp2 films are being processed. The 
powder consists primarily of beta-sheet and little alpha-helical conformation (2-7A, 2-
7D). After solubilizing and pouring, the film switches to an alpha-helical conformation 
with little beta-sheet content (2-7B, 2-7E). After he stretch bath and subsequent 
stretching the film reverts back to a beta-sheet conformation bringing it full circle (2-7C, 
2-7F). This increased beta-sheet content along with the alignment that occurs with 
stretching increases the energy to break over 20 times from the unprocessed films. 
Previous studies have shown β-sheet contributions at 1670 cm-1 and helical peaks at 1656 
cm-1 and assigned unordered peaks near 1640 cm-1. Figure 2-7B and 2-7E both appear to 
show an increased peak amplitude near 1656 cm-1 which further confirms the conversion 






These results show that rSSp films can be formed after dissolving them in an 
HFIP solution. It is clear that post-pour processing of films greatly increases the 
mechanical properties; these mechanical properties can be tuned to each application using 
Figure 2-7: Raman spectra of the progression of 
MaSp1 films (top) and MaSp2 films (bottom) in the 
amide III and amide I regions. Red arrows are used 
to emphasize structural changes occurring during 
production.  From top to bottom:  Purified protein 
powder (A, D), as-poured films from solubilized 
protein in HFIP (B, E), and films stretched in 80/20 
MeOH/water (C, F).  
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a combination of dope formulation, stretch baths, and stretch ratios. The addition of GTA 
to the dope before pouring also increases strain in films processed in 80/20 MeOH/Water 
without a significant change in secondary structure suggesting that GTA may induce 
crosslinking between proteins. Changing the processing conditions, such as stretch baths 
and stretch ratios, changes the conformation of the silk protein, making the secondary 
structure tunable for medical applications. The rSSp powder is initially in a beta-sheet 
conformation, after dissolving in HFIP and pouring the protein takes a mainly random 
alpha-helical conformation, after post-pour stretching the protein reverts to a beta-sheet 
rich conformation aligned in the stretch direction which has been confirmed by a 
combination of WAXD, Raman, and NMR.   










fiber 4000 35 4 
Recombinant 
spider silk 




film 54 1.8 41 
B. mori silk fibroin 
Ultrathin 
films 
100 0.5-3.0 38 
Collagen X-linked film 47–72 12–16 43 
Polylactic acid 
(PLA) 
sheet 28–50 2–6 38,44 




The results of these experiments also are the highest published stress and strain of 
any recombinant spider or silkworm silk films (Table 2-5), making it a strong candidate 
for use in biological systems. Spider silk is a biocompatible53 and biodegradable41 
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material suitable for use in multifunctional biomaterials. The comparison of MaSp1 and 2 
films also shows that with similar alignment and processing, the MaSp2 films do not 










Figure 2-S1: Diagram representing a C-
card used to load samples for mechanical 
testing. 
A B 
Figure 2-S2: AFM images 20 x 20 µm comparing different drying methods of MaSp2. (A) 




Table 2-S1: Comparison of vapor treatments with averages and standard deviations with a 
95% confidence interval. 
Treatments 
Average Energy to 





Cold 2.67 ± 1.85 65.73 ± 13.99 0.058 ± 0.03 
IPA 1.38 ± 0.51 79.61 ± 24.48 0.03 ± 0.004 
Methanol 2.46 ± 1.54 46.53 ± 12.23 0.097 ± 0.07 












Figure 2-S3: XRD images of MaSp1 (left) and MaSp2 (right) 
films post-pour stretched 2.5 times their original length after an 




MECHANICAL PROPERTIES OF RECOMBINANT SPIDER SILK FILMS II 
(WATER SOLVENTS)* 
*Co-Authors include: Justin A. Jones, J. Bennett Addison, Warner S. Weber, and Jeffery 
L. Yarger 
ABSTRACT  
Applications for spider silk films are broad, rangi from physical protection to 
biocompatible materials, making biological compatibili y of utmost importance. Our goal 
was to show optimization of dope formulation and post-pour methods for water solvated 
synthetic spider silk thin films making them both environmentally and biologically 
friendly. Films were made from synthetic forms of MaSp1 and MaSp2 from the dragline 
silk of Nephila clavipes.  We  surpassed the mechanical properties of HFIP based films 
by producing films from aqueous dopes with stress up to (206 MPa), with elongations as 
high as 35%after suitable post-pour stretching. The aqueous films have also been 
analyzed using NMR, XRD, and SEM, showing that the secondary structure of 
polyalanine sections in as-poured films is mainly alph -helical, but after post-pour 
stretching, this structure turns to beta-sheet crystallites aligned in the axis of stretch. 
INTRODUCTION 
Spider silk fibers have remarkable properties that could allow it to function in a 
variety of products including textiles, biomedical, nd manufacturing 
applications.4,8,21,36,37,47,55,61–63 Of particular interest is dragline silk with both a high 
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strength and elongation.4 In recent years, producing spider silks synthetically has become 
a major focus of research as spiders cannot be farmed since they are both territorial and 
cannibalistic. Efforts to produce these recombinant spider silk proteins (rSSP) have 
focused on producing of fibers47,61,62,64,65 while comparably little effort has been 
expended investigating alternative formations such as films, hydrogels, lyogels, and 
adhesives.   
Dragline silk is used as the lifeline for the spider and as structural support in the 
web and is one of the strongest natural fibers known to man.4 Dragline silk is made up of 
two different proteins: Major ampullate silk protein 1 (MaSp1)6 and Major ampullate silk 
protein 2 (MaSp2),7 each with a molecular mass of around 300 kDa. Native dragline silk 
is spun starting in the gland as a liquid dope, a viscous water based liquid crystalline 
solution 13,68 in a micelle-like structure.14 Beta-sheets are induced and aligned by the 
friction of the duct as it decreases in diameter12 and by the stretching of the fiber as it is 
pulled out of the spinneret. Duct cells also promote beta-sheet formation by removing 
water from the liquid crystal13 or micelle-like structure.14 As well, a change in pH and 
removal of ions has been demonstrated to occur as the protein dope solution rearranges 
from a liquid crystal to solid fiber.88 
Nuclear magnetic resonance (NMR),21,15–20,22,23 Raman spectroscopy,24,25 and X-
ray diffraction (XRD),16,26–29 show that secondary structures in spider dragline silk are 
mainly beta-spirals, beta-sheets, and glycine-II-helices. Beta-sheets confer mechanical 
strength to the silk and do not allow water penetration.23 Beta-sheets are mainly produced 
from the alanine-rich regions, (An) and (GA)n in the protein. Beta-turn spirals are made 
from the GPGGX (X is usually Y) and GPGQQ repeat uni s, and glycine-II-helices are 
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produced from the GGX regions.8 These glycine-rich peptide regions allow penetration of 
water and increase strain, which contributes to the overall toughness of the silk.2  
Synthetic spider silk fibers have been spun using rSSP to mimic natural spider 
silk properties.47,61,62,64,65 It has been shown that in order to produce stronger fib rs, 
higher molecular weight rSSp’s are beneficial.47 Dope formulation is also an issue, as the 
most effective at dissolving and forming films to date is 1,1,1,3,3,3-Hexafluoro-2-
propanol (HFIP). The native spinning process which involves the spider pulling the fiber 
is also difficult to mimic, as current systems utilize syringes to push the liquid dope out 
of small diameter (0.005” to 0.01” ID) PEEK tubing.64 The secondary structures in the 
fibers need to be induced and then aligned, done by a combination of a coagulation and 
liquid stretch bath(s).47,61,62,64 The fibers still have to be woven or braided together to 
form a product. 
 Spider silk films have been produced and the mechani al properties enhanced 
through different processing methods (HFIP paper). rSSPs are conventionally dissolved 
in HFIP- to create “dopes” that can be used to create fibers, films, gels, and foams, as 
well as electrospun fibers and mats.46,48,49,89 HFIP has been widely used and accepted as a 
standard solvent because it dissolves rSSPs at high concentrations (30% w/v), it is 
removed rapidly from the forming silk fiber, and does not interfere with fiber formation. 
In addition, rSSP’s are generally insoluble in aqueous solutions after purification. 
  There are significant problems with solvating rSSPs in HFIP or other organic 
solvents at an industrial scale. HFIP is toxic to human health and to the environment and 
has a high likelihood of having a cytological effect due to residual HFIP46 which was 
shown to occur in the previous chapter. HFIP is also not cost effective to purchase nor is 
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it simple to work with due to the need of a controlled environment.  To date however, 
there is no working process to efficiently dissolve rSSPs in any other solvent that would 
be less toxic and costly. There have been investigators that have used other solvents to 
produce fibers,13,61,68 but these have diminished mechanical properties Th inability to 
solubilize rSSPs in aqueous solvents limits the applications of synthetic spider silk.  
 This study focuses on a novel way of solubilizing rSSP in aqueous solvent to 
decrease environmental impact, cost of processing, a d toxicity. Even with the change of 
solvent, the mechanical properties of the films can be as much as, and in some cases, 
surpass those from films produced from HFIP. Post-pur rocessing methods will be 
utilized as previously described to improve secondary recruitment and orientation, and 
thus properties. 
MATERIALS AND METHODS 
MaSp1 and MaSp2 Purification 
Protein was purified as previously reported resulting in a protein powder which 
was used to make “dopes”. 
Dope preparation 
Standard water based films are made using dopes which contain 4% MaSp1, 2% 
MaSp2, and 3.5% 80/20 MaSp1/MaSp2 protein dissolved in water with additive. 
Additives were included in the dopes to improve solubility, antibiotics and crosslinking. 
These additives include formic acid (FA), acetic acid, arginine and glutamic acid, Urea, 
ammonium hydroxide, kanamycin, glutaraldehyde (GTA), and imidazole using multiple 
concentrations. The dopes are microwaved, using a 700W Magic Chef household 
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microwave, for a period of 30 seconds on full power in a sealed 3 mL Wheaton glass vial 
to liquefy the dope and solubilize the protein. The dope is transferred into a 
microcentrifuge tube and spun at 18000g for 1 min, the supernatant is transferred to 
another microcentrifuge tube and the centrifugation repeated to remove any particulate 
matter. All films are then immediately poured and spread onto four 30 x 7 mm 
polydimethylsiloxane (PDMS) strips with 200µL of dope on each strip. 
PDMS Mold   
 The mold is made from a PDMS (Dow Corning) solution of 5:1 base to initiator 
and poured it into a 90 mm petri dish to approximately 1 mm thick. The petri dish and 
solution is then placed into a vacuum chamber for 20 minutes to remove all bubbles. 
They are then placed in an oven at 70 ºC to crosslink overnight. The solidified PDMS is 
removed and cut using a forceps and a razorblade to four 30 x 7 mm strips (Figure 3-1), 
with care taken to keep it clean of particulates. The mold is then thoroughly cleaned using 





Figure 3-1: PDMS strips with 




The dope is carefully pipetted (200 µL) out of the microcentrifuge tube and 
poured onto a pre-made PDMS strip (described above) in a Thermo Scientific Hamilton 
Concept chemical hood with the sash opened to provide air flow over the films and 
decrease drying time (Figure 3-1). After 1 day the films are dry, and starting to peel 
themselves off of the strips. The films are removed using forceps and the edges cut with a 
razor blade, producing a uniform flat film, as in the previous chapter. 
Post-Pour Treatments 
Post-pour processing is done as described in the previous chapter. Briefly, films 
are glued to a stretching apparatus, and then submerged into a mixture of alcohol and/or 
water for a period of 2 minutes. The films are then taken out of the solution and stretched 
by mechanical means. The stretch ratio is determined by dividing the final length by the 
initial length.  For example, an 8.5 mm film achieves a stretch ratio of 3X when the 
stretching device reaches an endpoint of 25.5 mm. The films are then cut to a specific 
length and width to weigh them and calculate the thickness using a density of 1.23 
g/cm.77–79 
Mechanical Testing 
The films are mounted on a plastic C-card length wise using Loctite super glue 
(liquid) across an 8 mm gap.80  After mounting, the C-card is loaded on an MTS Synergie 
100 (50N load cell) by clamping the top and bottom f the card into the instrument and 
cutting the side of the C-card so the only thing being tested is the film.65 The film is then 
tested to breaking at 5 mm/min, with data collection at 30 Hz to measure the film’s load, 
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from which stress, strain and energy to break can be calculated using MTS’s TestWorks 
4, 2001. 
Nuclear Magnetic Resonance (NMR) 
All 13C solid-state NMR data were collected on a 400 MHz Varian Wide-Bore 
instrument using a 1.6 mm solids triple resonance probe.  Samples were packed into a 1.6 
mm zirconia rotor and spun at the magic angle at 30 kHz MAS.  1H - 13C cross 
polarization (CP) conditions were calibrated using 13C-Glycine, and the CP condition 
was met by using a ramped (~15%) 1H spin-lock pulse centered at 130 kHz RF field 
strength, and a square spin-lock pulse on the 13C channel matched to the -1 spinning side 
bands of the Hartmann Hahn profile.  All spectra were collected using a 50 kHz spectral 
width, 8 ms acquisition time, 12288 scan averages, a 1 ms CP contact time, a 5 second 
relaxation time, and 150 kHz two-pulse-phase-modulated (TPPM) decoupling was 
applied on the 1H channel during acquisition.  50 Hz exponential line broadening was 
applied to each spectra prior to Fourier transform.  The 13C chemical shifts are 
referenced externally to TMS at 0 ppm by setting the downfield resonance of adamantane 
to 38.56 ppm. 
Raman  
The films were analyzed using a home built Raman system. Films were placed 
bridging the space between two parallel glass slide to eliminate background and excited 
with a 150 mW 532 nm Coherent Sapphire SF laser focused onto the sample with a 50x 
magnification APO plan Mitutoyo 2.0 cm working-distance objective. The laser power 
was controlled using neutral density filters to make the power at the sample 28 mW 
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which optimized the balance between signal-to-noise and sample damage. The Raman 
signal was collected in back scattering geometry.The laser wavelength was discriminated 
from the Raman signal using an Ondax SureBlock(TM) ultra-narrow-band notch filter. 
An Acton Research SpectraPro 300i monochromator with a 1200 g/mm grating coupled 
to a PI liquid nitrogen cooled CCD detector was used to collect Raman signal for 5 
acquisitions of 60 seconds each at a resolution of 1.5 cm-1.  Cyclohexane and 
acetaminophen were used as calibrants. 
X-Ray Diffraction (XRD) 
Samples were taken to the Advanced Photon Source located at Argonne National 
Laboratory, Argonne IL, USA and wide-angle x-ray fiber diffraction was performed on 
the BioCars 14BM-C beamline using a beam energy of 12.6 keV and approximate size of 
130 x 340 µm.  Films were mounted and were placed at a distance of 300mm from the 
ADSC Quantum-315 9-panel CCD array detector. Stretched films were placed with the 
stretched axis parallel to the beamstop and mounted to a goniometer. The exposure time 
was 60 seconds for each of ten images averaged for each sample. For each sample, 5 
background images were taken following each sample with the same parameters and 
calibrated with CeO2. Images were then processed using Fit2D software and Matlab. The 
MaSp2 films were contaminated while at the synchrotron source and made the x-ray 
diffraction data unusable. 
Field Emission Scanning Electron Microscopy (FE-SEM) 
The Films were imaged by field emission scanning electron microscopy (FE-SEM 
Hitachi S-4000, Hitachi High-tech Corporation, Toky, Japan) to characterize their 
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morphology. The films were mounted on an aluminum stub and coated with a gold layer 
10 nm thick.  
Film Functionalization  
HFIP dopes were made by dissolving 50 mg of MaSp1 powder in 1 mL of HFIP 
and mixed overnight, 200 µL was poured into a PDMS mold (described in HFIP paper) 
and allowed to dry. The kanamycin containing film was made by transferring 300 µL to a 
new vial and adding 1 µL of kanamycin stock (15mg/mL), mixed for a minute using 
rotary agitation, and then 200 µL was poured into a PDMS mold.  
The water based dope was made by microwaving 15 mg MaSp1 powder in 300 
µL of water for 45 seconds and pouring 200 µL onto a PDMS strip as described above. 
The kanamycin film was made the same way with the exc ption that the rSSP solution 
was allowed to cool ot room temperature to prevent d gradation of the kanamycin. One 
µL kanamycin (15mg/mL) was added to the dope for a final concentration of 50µg/mL. 
The dope was mixed for a minute using rotary agitation before pouring 200 µL onto a 
separate PDMS strip. 
Two days after pouring the films, a lawn of E. coli XL1-Blue cells was 
established on an LB agar plate and allowed to dry for 30 min in an incubator at 37 °C. 
Holes (6.5 mm) were punched out of the films and a disc from each film was placed on 






 All statistical analyses done on mechanical properties were done using a one-
tailed t-test assuming equal variance with a null hypothesis that the sample means are 
equal. A p-value of < 0.05 is considered significant. 
RESULTS AND DISCUSSION 
The stability and processing of spider silk films depend on the composition of the 
dope. Dope preparation began by using recombinant MSp1, water, and formic acid (0.1, 
0.5, 1, 5, 10, 15, and 20 %), acetic acid (10, 15, and 20%), arginine and glutamic acid 
(Arg Glu) (0.6, 12, 20, 30, 50, and 122 mM), Urea (4, 8, 160 mM), ammonium hydroxide 
(50, 100, and 200 mM) or Imidazole (10 and 100 mM). aSp2 films were also made 
using formic acid (0.1, 2, 10, and 20%) and acetic ac d (1, 5, 20%).  All additives were 
placed into the dope prior to microwaving.   
 Preliminary tensile testing was done on the films as-poured (no processing). 
These films were screened for tensile strength, solubility, and processability. Solubility 
was tested by putting the films into 5 mL of DI water. Processability was determined by 
trying to stretch the films in different stretch baths, it was determined processable if the 
film stretched without breaking to a minimum of 1.5X  Films from dopes containing urea 
and ammonium hydroxide dissolved quickly in water (< 30 sec). Urea containing dope 
films also dissolved in a mixture of alcohol and water, preventing further processing of 
films (Table 3-1). The dope made with 0.1% formic acid proved to make films with a 





Table 3-1: Comparison of mechanical properties and solubility of films made from 
different dope formulations using MaSp1. Showing aver ges ± standard deviation 









Urea 4mM 0.42 ± 0.12 50.26 ± 8.62 1.7 ± 0.3 Y 
8mM 0.43 ± 0.05 50.70 ± 3.04 1.7 ± 0.1 Y 
160mM 0.44 ± 0.14 49.97 ± 7.74 1.6 ± 0.3 Y 





0.6 mM 0.64 ± 0.22 61.82 ± 13.06 2.0 ± 0.4 N 
12 mM 0.75 ± 0.25 58.31 ± 7.94 2.3 ± 0.6 N 
20 mM 1.96 ± 3.13 50.32 ± 11.99 4.5 ± 5.3 N 
30 mM 8.71 ± 8.74 22.67 ± 2.62 43. ± 39.7 N 
50 mM 7.47 ± 6.67 15.64 ± 0.66 51.2 ± 45.3 N 
122 mM 0.07 ± 0.02 3.24 ± 0.9 3.6 ± 0.5 N 
      
Ammonium 
Hydroxide 
50 mM 0.41 ± 0.12 52.55 ± 6.86 1.7 ± 0.3 Y 
100 mM 0.71 ± 0.24 62.83 ± 15.49 2.5 ± 0.6 Y 
200 mM 0.68 ± 0.22 57.81 ± 11.98 2.4 ± 0.5 Y 
      
Formic 
Acid 
0.10% 0.61 ± 0.17 53.97 ± 4.73 2.5 ± 0.4 N 
0.50% 0.69 ± 0.19 58.15 ± 8.2 2.5 ± 0.2 N 
1% 0.84 ± 0.22 69.35 ± 7.28 2.6 ± 0.4 N 
5% 0.84 ± 0.4 65.24 ± 14.3 2.5 ± 0.7 N 
10% 0.64 ± 0.12 60.76 ± 7.52 2.4 ± 0.3 N 
15% 0.81 ± 0.04 71.36 ± 5.1 2.5 ± 0.2 N 
20% 0.87 ± 0.2 66.56 ± 7.4 2.7 ± 0.4 N 
      
Acetic Acid 10% 2.63 ± 1.18 50.56 ± 5.63 6.9 ± 3.0 N 
15% 0.94 ± 0.22 50.35 ± 9.17 3.4 ± 1.0 N 
20% 24.28 ± 9.43 36.58 ± 2.24 82.6 ± 29.6 N 
 
Tensile testing was done to understand variability between samples, structural 
integrity and extension of the films (Table 3-1). It was previously hypothesized that high 
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extension (> 0.100) and low stress (≤ 50 MPa) led to a film that could be easily post-pour 
stretched as indicated by the results from the previous chapter. This hypothesis was 
disproved as dope formulations making as-poured films with a high degree of 
extensibility (20% acetic acid and 30mM arginine and glutamic acid) could not be further 
processed. Dopes containing propionic acid (0.1 and 10%) and imidazole (10 and 
100mM) were also made, preliminary mechanical testing was not done on these films as 
they also broke when force was applied in the stretch bath.  Films with 0.1% formic acid 
permitted alcohol and water treatments, as well as stretching, both of which increased 
mechanical properties. Due to the ease of processability, the dope formulation containing 
0.1% formic acid was used for the remainder of the experiments. Additionally, 0.05% 
GTA was also used due to previous work showing that i  increases both stress and strain. 
A similar problem was encountered when MaSp2 films were stretched using any variety 
of alcohol and water concentrations, breaking the films instead of actually stretching 
them.  To solve this problem MaSp1 was mixed in with MaSp2 at different 
concentrations until the films were able to be processed, arriving at 80% MaSp1 and 20% 
MaSp2 based on weight. 
Films that were made with 0.1% formic acid and 0.05% GTA were then 
characterized using XRD, showing that the MaSp2 films have more crystallinity than the 
MaSp 1 films (Figure 3-2 and 3-S1 at end of chapter). The pure MaSp2 films also were 
not able to be post-pour stretched, it is hypothesized that this is due to the high beta-sheet 
content preventing the penetration of water. MaSp2 dopes also gelled faster than MaSp1 
dopes after microwaving, due to the higher beta-sheet content, making it difficult to 





Figure 3-2: XRD images of as-poured spider silk films MaSp1 (A), 
post-pour stretched 2.5 times its original length af er an 80/20 
Methanol/Water bath (B), 1D radial integration profile of the whole 2D 
pattern of B (C), and the 1D azimuthal intensity profile of B (D). The 
double arrow in A and B represents the direction of film stretch 
alignment which is parallel to the beamstop shadow (blue). 
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The surface of the MaSp1 films were also imaged using a scanning electron 
microscope (SEM), showing that the film after stretching remains smooth (Figure 3-3). It 
also shows that the cut edge of the film may be porous or damaged due to cutting. This is 
not a desirable feature, but the films need to be cut to remove the thick edges. Using these 




Following the preliminary testing of the dope compositi ns,  films (both MaSp1 
and 80/20 MaSp1/MaSp2)  with 0.1% formic acid and 0.05% GTA were stretched in a 
combination of water and alcohol resulting in the highest energy to break (62 MJ/m3) for 
recombinant silk protein films (Table 3-2 and Figure 3-4).  The results of mechanical 
testing also demonstrate that 80/20(w/w) MaSp1/MaSp2 films treated in 80/20 (v/v) 
MeOH/water yield the highest stress with a lower stretch ratio. Using this treatment, 
films cannot be stretched past 2.7X without breaking. Treating 80/20(w/w) 
MaSp1/MaSp2 films in 50/50(v/v) IPA/water increases the energy to break with a 39% 
strain and moderate (177 MPa) stress.  With a higher str tch ratio and using the described 
Figure 3-3: SEM image of the surface (A) and 
cut edge (B) of stretched MaSp1 films after 
80/20 MeOH/water 2.5X stretch. Arrow 
indicates stretch direction. Scale bars: A. 30 





treatment, films can be post-pour stretched up to 3.2 X their original length, although 
stretching past 3X results in reduced strain.   
Table 3-2: Mechanical properties of films with average ± stand rd deviations with a 95% 
confidence interval  after post-pour stretch using set ratios of IPA, MeOH, and water 












MaSp1 + 50/50 IPA/Water 2.5X 30.44 ± 3.55 136.66 ± 2.06 0.253 ± 0.02 
MaSp1 + 80/20 MeOH/Water 2.5X 40.6 ± 3.34 149.42 ± 7.27 0.335 ± 0.02 
80/20 MaSp1/MaSp2 + 80/20 MeOH/Water 2.5X 40.58 ± 10.9 168.35 ± 20.76 0.307 ± 0.1 
80/20 MaSp1/MaSp2 + 80/20 MeOH/Water 2.7X 47.06 ± 3.08 206.81 ± 3 0.289 ± 0.02 
80/20 MaSp1/MaSp2 + 50/50 IPA/Water 3X 52.36 ± 8.02 183.92 ± 14.85 0.354 ± 0.07 




Figure 4: Histogram of the mechanical properties for stretched films showing average stress, 
strain, and energy to break where bar height represnts the average value, and x the median with 
dashes representing maximum and minimum values. 
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Wide-angle X-ray diffraction of the films yields nao-crystalline Bragg 
reflections and an amorphous halo. The XRD pattern shows that the crystalline structure 
within the stretched films is also aligned parallel to the stretch direction, with a calculated 
Herman's orientation factor, fc, of 0.823 for MaSp1, determined from azimuthal 
broadening of the equatorial reflections where  %& is calculated (equation 2) from the 
angle, φ, between the longest axis and the fiber axis (Figure 3-2). 
%&  &'(
)*+
    (2) 
Radial integration along the equator gives the peak positions and widths of the 
(200) and (120) reflections which are used to calcul te the a and b axes of the unit cell 
and nanocrystal dimensions. Along the meridian, the (002) reflection gives the 
information concerning of the c-axis of the unit cell. Spider silk proteins have been 
shown to form orthorhombic unit cells and the unit cell dimensions calculated from the 
peak positions of wide angle X-ray diffraction WAXD reflections are calculated from 









&)    (3) 
Radial integration along the equator (Figure 3-2C) and meridian were fit to 
Gaussian peaks and the peak positions were converted to inverse space following Bragg’s 
Law to calculate unit cell dimensions. Average crystallite size in each dimension is 
calculated from the radial broadening in 2θ space using Scherrer’s formula and these 





Table 3-3: Unit cell and crystallite dimensions calculated from 
WAXD. 
Material Unit cell (Å) Crystallite (nm) 
MaSp1 post-stretch 
film 
6.92 x 8.86 x 
11.37 
1.93 x 3.34 x 7.86 
 
 
The crystallinity, xc, can be estimated by radial integration of the equatorial 
reflections which are the crystalline peaks due to Bragg diffraction relative to the full 
integrated peak area yielding 48.8% crystallinity for MaSp1.84 
3&  456789.67, 7:;.6'9<.2 97=27&6<'5(>;22 9.,<.2 <56789.6<'5     (4) 
 The molecular protein structure of the films was tracked through successive 
stages of film production using 1H – 13C CP-magic angle spinning (MAS) NMR (Figure 
3-5).13C chemical shifts are very sensitive to protein secondary structure, and can 
therefore be utilized to monitor structural changes throughout film production.  Chemical 
shifts that arise from alanine Cα and Cβ in either a beta-sheet or helical/random coil 
conformation are indicated with dotted lines in Figure 3-5.  The films are essentially 
produced from powder to final product; initial MaSp1 rotein powder (Figure 3-5A) is 
solubilized into an aqueous-based silk dope, which is cast as an as-poured film (Figure 3-
5B).  The poured films are then submerged in a bathof 80/20 MeOH/water and stretched 
2.5X (Figure 3-5C).  The data shows that the purified MaSp1 protein powder (Figure 3-
5A) is dominated by alanine in a beta-sheet conformation.  When the silk protein is 
solubilized and cast into films, the data reveals that alanine originally in a beta-sheet 
55 
 
conformation is partially converted to helical or random-coil structures.  Similar to HFIP 
solubilization, it appears that dissolution of silk protein in an aqueous medium is 
correlated with a decrease in alanine adopting a bet -sheet structure (Figure 3-5B).  
However, the more stable beta-sheet structure is recovered when the as-poured films are 
stretched in 80/20 MeOH/water (Figure 3-5C). These r ults are consistent with trends 
observed for HFIP based films with the exception that ere is no HFIP peak in aqueous 
films. This would lead us to believe that we are essentially creating the same films using 
a water based dope vs. HFIP, lowering the cost of materials, improving biocompatibility 
and improving the environmentally friendly aspect of his biomaterial.  
Raman spectroscopy characterization was also done on the spider silk powder, 
untreated films and post stretch films (Figure 3-6). These results confirm the previous 
findings of NMR that the powder consists primarily of beta-sheet and little alpha-helical 
conformation, after solubilization and pouring, thefilm converts to an alpha-helical 
conformation with little beta-sheet content, and after stretch bath and subsequent 
stretching the film reverts back to beta-sheet content. These results are also similar to 







Figure 3-5: 1H-13C CP-MAS spectra of MaSp1 films in various stages of pr duction.  
Resonances for alanine and glycine residues are highlighted with dotted lines, and protein 
secondary structure is indicated when appropriate.  The data suggests that the MaSp1 starting 
material (A) originally contains a significant β-sheet component.  The protein is then solubilized 
in an aqueous-based silk dope, where the β-sheet fraction is expected to have decreased during 
solubilization. Films poured from this dope indeed show a decrease in β-sheet content (B).  β-






 As proof of concept, to show the potential for these spider silk films in medical 
applications, two water based films and two HFIP films were produced, the first of the 
two contain kanamycin in the dope and the second cotain no additives. The films were 
placed on an agar plate that had been seeded with XL-1 Blue cells (Figure 3-7). Both 
HFIP and water based films containing kanamycin generated a zone of inhibition on the 
bacterial lawn. Water based films without kanamycin produced no zone of inhibition; 
however the HFIP based film without kanamycin produced a narrow zone of inhibition, 
demonstrating that there is a cytological effect (residual HFIP) preventing growth of 
cells.90 
Figure 3-6: Raman spectra of the progression 
of MaSp1 films in the amide III and amide I 
regions.  From top to bottom:  Purified 
protein powder (1), as-poured films from 
solubilized protein (2), and films stretched in 






 Results show that films can be produced from water based solutions and the 
mechanical properties increased and customized by using both 80/20 MeOH/water and 
50/50 IPA/water stretch baths. The results from these xperiments show that the poured 
films are mainly in an alpha-helical conformation, although after processing the 
conformation converts to aligned beta-sheet similar to HFIP based films. Thus, aqueous 
derived rSSP films reduce the cost of production, the toxic impact on the environment 
and improves biocompatibility over similar HFIP deriv d films. Due to the aqueous 
nature of the dopes, further functionalization may be more possible with aqueous films 
than with HFIP or other organic solvent derived rSSP materials. HFIP solvates rSSP by 
converting the tight beta-sheet structures to alpha-helical or random coil structures, 
Figure 3-7: Zone of inhibition of films with 
and without kanamycin. HFIP based film with 
kanamycin (A), HFIP based film (B), water 
based film with kanamycin (C), and water 





















negating the possibility of functionalizing the rSSP with protein therapeutics as they 
could also be denatured.  
Table 3-4: comparison of the mechanical properties of silk, collagen, and 








Spider silk (dragline) fiber 4000 35 4 
Other recombinant 
spider silk 
film 54 1.8 41 
B. mori silk fibroin 
Ultrathin 
films 
100 0.5-3.0 38 
B. mori silk fibroin 
fiber 
mats 
510–650 ∼32 38,42 
Collagen film 0.9–7.4 24–68 43 
Collagen X-linked film 47–72 12–16 43 
Polylactic acid 
(PLA) 
sheet 28–50 2–6 38,44 
ABS plate 40 25 44 
PMMA plate 55–76 2–5 44 
 
Maximum stress values of over 200 MPa were observed in processed aqueous 
films with a maximum energy to break over 60 MJ/m3, and maximum strain over 40%. 
These values are the highest mechanical properties reported on materials used as a 
scaffold for cell growth (Table 3-4), with a stress at least double that of all others and 
strain higher than all but collagen.  As well, films generated from rSSP solvated in water 





















Figure 3-S1: 2D WAXD images of as-poured 







The use of water instead of HFIP in the dope construct for film formation has the 
potential to change the processing of spider silk products due to its cost of production and 
significant lowering of toxicity to the environment and people. We have been able to 
produce a water based film that is similar in structure and mechanical abilities to HFIP 
based films, which makes the water based films even more valuable. 
Analysis of cost on the preparation of one milliliter of dope solution shows that 
the HFIP dopes cost more than 1,000 times that of water based dopes. With that 
information alone we can determine that the creation of films using a water based process 
is more efficient. The water based dopes also have the added benefit of being “green,” by 
totally eliminating the use of HFIP and using less than 0.2% formic acid and 
glutaraldehyde in the formulation of dopes.  
Dope preparation for HFIP based films was established from previously proven 
formulations,46,48,49,89 changing the concentration of spider silk to increase thickness and, 
therefore, increasing ease of handling. Formic acidwas also added to the dope due to 
unpublished data regarding fiber formation in the Lewis Lab. For the switch to water 
based dopes, the dope formulations needed to be completely re-explored using different 
reagents to ensure solvation and processability. The reagents probed were acids (formic, 
acetic, and propionic), amino acids (arginine and glutamic acid), a base (ammonium 
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hydroxide), and urea. Reagents were investigated for their ability to solvate 4% protein 
and the films were tested for solubility in water. Select films were also tested for 
mechanical properties. 
Pouring methods were also slightly changed from HFIP films to water based 
films, pouring on top of strips instead of into wells. A mold needed to be made due to the 
hydrophobicity of PDMS creating a gap in the corners of the HFIP mold and making 
films that were not consistently wide or long. This problem was solved by making molds 
without edges, to avoid null space, and that the liquid could be poured on top of.  
Films were also analyzed using NMR, XRD, and SEM or AFM. These analyses 
demonstrate that the films produced in both methods are very similar with the exception 
that water based films have a higher crystalline content in both MaSp1 and 2, making the 
water based MaSp2 films unable to be stretched. Another difference between HFIP and 
water based films is that residual HFIP is found in as-poured films, which is toxic to cells 
films (Figure 2-6). In regards to the MaSp1 films, both water and HFIP based films have 
similar structure, with the exception that the as-poured water based MaSp1 films have a 
higher beta-sheet structure. Stretching the water based films results in similar alignment 
and secondary structure to HFIP based films, creating essentially the same film. 
 
Future Work  
With an understanding of film formulation, formation, processing, physical 
properties, and mechanical properties, experimentatio  regarding different applications 
can begin. As stated earlier, the applications for films are far reaching, but the most 
interesting application is their use in the medical field. Therefore, I think the next step in 
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testing films are to implant them into mammals and get a better understanding of how the 
body responds to them and how they interact with the body. Growing multiple types of 
cells on these films can also give a better understanding of other feasible applications.  
Other areas that can be further explored are lyogels, hydrogels, adhesives, and 
coatings for medical applications. Testing in these areas would include using films as a 
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ENGINEERING BACKGROUND: CONSIDERATIONS FOR CTE 



















Chronic traumatic encephalopathy (CTE) is a progressiv  degenerative brain 
disease caused by repetitive brain trauma. CTE is associated with memory disturbances, 
behavioral and personality changes, Parkinsonism, and speech and gait abnormalities 91. 
The disease can only be diagnosed by post-mortem exa ination of the brain. While 
regular media reports on CTE are a new phenomenon, the problem itself is an old one. 
Pathological case reports, mostly in boxers, have been published for decades .92 In a 
recent study, 34 out of 35 professional football players and 9 of 9 college football players 
were positive for CTE. Although this case series wabi s because families are more 
likely to donate if the donor was exhibiting abnormal symptoms, 92 this is still an 
astounding number. This not only affects professional level football players; high school 
football players alone suffer 43,000 to 67,000 concussions per year, which could leave 
them susceptible to CTE. More than 50% of concussed athletes are suspected of failing to 
report their symptoms. 93 These data, along with the more than 4,000 former NFL
football players filling lawsuits on the matter, show a need for changing the protective 
gear used in football. The limitations on the materi l being used for helmets has been 
reached; therefore, it is time to replace it with a m terial that can absorb the impact and 
transfer it around the head instead of directly into t. A new impact resistant helmet will 
decrease the number of concussions seen on the field and subsequently increase the 






Spider dragline silk has proved to be one of the toughest natural fibers known to 
man. 94 Although research has been done to characterize the structures of synthetic spider 
silk before and after a methanol treatment 48 and the solubility of such films, 49 there is no 
published research exploring the optimization of mechanical properties for synthetic 
spider silk films. Films can be used instead of fibers because they do not need to be 
woven together after processing, which significantly reduces the cost of production. The 
results of this research shows that these films’ energy absorbance has been increased 40 
fold compared to non-processed controls. The same outer shell on football helmets has 
been used since the 1980s.95 The material currently being used is a plastic called 
polycarbonate and it has a tensile strength of 55-75 MPa and extension of 38-40%, while 
spider dragline silk has a tensile strength of 1.2 GPa and an extension of 35%, and the 
spider silk films made in this project have a tensile trength of up to 200 MPa and 35% 
strain. The films will at least double the energy absorbance of the material and will 
dissipate the energy being applied around the helmet. When looking at the strength of 
capture webs it is important to note that, as the web stretches, energy is being distributed 
throughout the web, which is why spider silk webs are so efficient. The reason why webs 
absorbs energy so well is because the tensile strength of the fibers increase as the web 
stretches.96 Polycarbonate cannot absorb energy as well because it reaches a point of 
plastic deformation at which tensile strength no longer increases.97 This spider web 
energy absorbent technology can be used in the helmet system: as the outer shell is 
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stretching from the impact, the energy is distributed around the head, preventing 
concussions. 
The film that I would choose for this particular application would be the water 
based, 80/20, M4/M5 film that had been stretched in 50/50 IPA/water 3X because these 
films have the highest energy to break and the highest strain. Using this type of film will 
increase its ability to bend when hit and absorb the impact better than the film that has the 
highest strength. I would choose the water based films because they are less expensive 
and would have a minimal impact on the environment. 
The use of spider silk films instead of the polycarbonate would be a better choice 
due to the strength of the spider silk films and the aspect of decreasing weight. With a 
material that is 3-4 times stronger, the amount of material needed will be less, leading to 
a lighter product. 
Possible Problems and Alternative Strategies: 
Since most of the techniques described above have already been proven to work, 
the potential problems are minimal. The biggest problem that could slow research is the 
transition from small films to large films. Large films might not be as strong as the 
smaller films. Regardless of this problem, research can continue. Even if the larger films 
have slightly decreased mechanical properties, we still anticipate that they will absorb 
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[0001] This application claims priority to United States Provisional Patent Application 
No. 61/865,487, filed August 13, 2013, the entirety of which is herein incorporated by 
reference. 
FIELD OF THE INVENTION 
[0002] The present invention is directed to a method of forming recombinant spider silk 
protein films and 
more particularly, the present invention is directed to methodology for synthesizing the 
film and uses of the film in various industries. 
BACKGROUND OF THE INVENTION 
[0003] The use of recombinant spider silk proteins is well recognized in the art and has 
been set forth in United States Patent No. 7,056,023, issued June 6, 2006, to Islam et al., 
the contents of which is incorporated herein by refer nce. Generally, the disclosure 
explains methods and apparatuses for spinning silk protein fibers from recombinant 
proteins. The methods are primarily useful for spinning fibers of spider silk or silkworm 
silk proteins from recombinant mammalian cells and may be used to spin such fibers for 
use in the manufacture of industrial and commercial products. 
[0004] Further examples of advancements in the art include that which is taught in United 
States Patent No. 7,754,851, issued July 13, 2010. In this reference, Scheibel t al. 
explain spider silk proteins, nucleic acids, coding for these recombinant spider silk 
proteins, as well as hosts suitable for expressing those nucleic acids. Further, there are 
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discussions centred on a method of aggregation of spider silk proteins and the use of the 
proteins in the field of biotechnology and/or medicine and other industrial fields, 
particularly in the manufacture of automotive parts, in the aircraft construction, in the 
processing of textiles and leather, as well as in the manufacture and processing of paper 
.In United States Patent Application Publication US 2009/0263430, published October 
22, 2009, Scheibel et al., discuss a method of forming multilayer silk protein films and a 
multilayer film obtained therefrom. Various materials, products and compositions 
containing the multilayer film are also taught as well as the use of the film in several 
applications. 
[0005] Other examples of the progress in this area of technology include developments 
evinced in United States Patent Nos. 7,521,228; 5,989,8 4; 7,521,228; 5,989,894; 
5,733,771; 5,756,677; 5,733,771; 5,756,677; 5,994,099 and 7,723,109 inter alia. 
SUMMARY OF THE INVENTION 
[0006] One object of one embodiment of the present invention is to provide an improved 
recombinant spider silk protein film. 
[0007] Another object of one embodiment of the present invention is to provide a new 
protocol for 
forming a recombinant spider silk protein film. 
[0008] A still further object of one embodiment of the present invention ids to provide a 
method of 
forming silk protein film comprising the steps of: 




suspended in a suitable solvent; 
b) mixing said solution with a compound selected from the group comprising water, 
acids, 
imidazole, crosslinking agents, antibiotics, nanoparticles , surfactants and combinations 
thereof; 
c) exposing the solution to microwaves for a period sufficient to solubilize the protein; 
d) pouring the microwave treated solution onto a substrate; and 
e) drying said film. 
[0009] Another object of one embodiment of the present invention is to provide a method 
of forming silk protein film comprising the steps of:
a) providing a solution containing between 1 and 15 % by weight of silk proteins 
dissolved or 
suspended in a suitable solvent; 
b) mixing said solution with a compound selected from the group comprising 
hexafluoroisopropanol (HFIP), acids, imidazole, crosslinking agents, antibiotics, 
nanoparticles, surfactants and combinations thereof; 
c) mixing said solution for a period sufficient to s lubilize the protein; 
d) pouring the mixed solution onto a substrate; and 
e) drying said film. 
 [0010] A still further object of one embodiment of the present invention is to provide a 
method for 
modifying mechanical property of a recombinant spider silk protein film, comprising: 
a) providing a film made in accordance with claim 1; 
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b) providing an alcohol and water mixture; 
c) conditioning said film in a conditioning step including stretching said film when said 
film is 
either within said mixture or out of said mixture; and 
d) maintaining said film, when conditioned with said mixture, in said mixture for a period 
between 30 seconds and 10 minutes whereby a mechanical property of said film is 
modified 
relative to an unconditioned film. 
[0011] A further object of one embodiment of the present invention is to provide a 
method for modifying 
mechanical property of a recombinant spider silk protein film, comprising: 
a) providing a film made in accordance with claim 1; 
b) providing an alcohol and water mixture; 
c) conditioning said film in a conditioning step including stretching said film when said 
film is either within said mixture or out of said mixture; and 
d) maintaining said film, when conditioned with said mixture, in said mixture for a period 
between 30 seconds and 10 minutes whereby a mechanical property of said film is 
modified relative to an unconditioned film. 
[0012] Another object of the present invention is to provide a method for modifying 
mechanical property of a recombinant spider silk protein film, comprising: 
a) providing a film made in accordance with claim 17;
b) providing an alcohol and water mixture; 
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c) conditioning said film in a conditioning step including stretching said film when said 
film is either within said mixture or out of said mixture; and 
d) maintaining said film, when conditioned with said mixture, in said mixture for a period 
between 30 seconds and 10 minutes whereby a mechanical property of said film is 
modified relative to an unconditioned film. 
 [0013] These objects are solved by the subject-matter of the independent claims. 
Preferred 
embodiments are set forth in the dependent claims. 
[0014] Having thus generally described the invention, reference will now be made to the 
accompanying drawings, illustrating preferred embodiments. 
BRIEF DESCRIPTION OF THE DRAWINGS 
[0015] FIGURE 1A is a view of a fiber spun where the dope had not been sonicated; 
[0016] FIGURE 1B is a view of a fiber spun where the dope had been sonicated; 
[0017] FIGURE 2 is a schematic illustration of the C-card used in the testing of the films; 
[0018] FIGURE 3 is a schematic illustration of the stretching device used for stretching 
the films; 
[0019] FIGURE 4 is an X-ray diffraction pattern for the film from Example II; 
[0020] FIGURE 5 is an illustration of the films from Example VI as positioned on a lawn 
of E. coli on LB agar; 
[0021] FIGURE 6 is an X-ray diffraction pattern for the film from Example VII; 
[0022] FIGURE 7 is an X-ray diffraction pattern for the film from Example XI; 
[0023] FIGURE 8 is an X-ray diffraction pattern for the film from Example XII; 
[0024] FIGURE 9 is an X-ray diffraction pattern for the film from Example XIII; and 
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[0025] FIGURE 10 is an X-ray diffraction pattern for the film from Example XIV 
[0026] Similar numerals employed in the drawings denote similar elements. 
[0027] Unless otherwise defined, all technical and scientific terms used herein have the 
same meaning as commonly understood by one of ordinary skill in the art to which this 
invention pertains. All publications, patent applicat ons, patents, and other references 
mentioned herein are incorporated by reference in their entirety. In case of conflict, the 
present specification, including definitions, will control. In addition, the materials, 
methods, and examples are illustrative only and not intended to be limiting. 
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS 
[0028] The importance of spider silk for industrial applicat ons cannot be overstated. It 
has ubiquitous utility in the processing of paper, cosmetics, food, electronic devices, drug 
delivery and in the automotive industry particularly for airbags and tires. Airbags, as is 
well known, are designed to push the passenger back into the seat without absorbing the 
full impact of the force. Employing spider silk in airbags, would provide more flexibility 
and absorb more energy. This could make airbags a more effective lifesaver. 
[0029] In respect of tires, currently, tires have Kevlar co ds on the inside which makes 
the tires strong and reliable. The problem with Kevlar it that it has a tendency to blow up, 
that is the reason why tires explode. Fibers made with spider silk in the tires would allow 
the tire to absorb more impact, making explosions unlikely. 
[0030] Particularly convenient is the fact that the film can be combined with a 
innumerable examples of substrates such as a cosmetic composition, a pharmaceutical or 
medical composition ,drug delivery system, artificial cell, contact lens coating, sustained-
release drug delivery system, artificial skin graft; food composition; automotive part; 
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aeronautic component; computer or data storage device, building material, textile, filter 
material, membrane material, nanomaterial, electronic component and combinations 
thereof. 
[0031] With the degree of activity in this area of technology and despite the voluminous 
amount of prior art that has been created, there still xists a need for expedient protocols 
for recombinant spider silk protein film synthesis for use in a wide variety of industries as 
well as a film synthesized in accordance with the protocols having superior mechanical 
properties. This would lead to use of the synthesized film material into the automotive, 
pharmacological, medical, manufacturing, food, clothing, electronics, interalia. 
[0032] Advantageously, the present invention in its many facets now presents an elegant 
synthesis protocol and product to address the void in this technology area. 
Protein Preparation 
[0033] Prior to a presentation of the synthesis of films using the spider silk protein, one 
possible route for the formulation of the protein is d scussed below for general 
background. 
[0034] Recombinant spider silk proteins, rSSPs, are conventionally dissolved in a very 
harsh organic solvent, 1,1,1,3,3,3-hexafluoroisopropan l (HFIP), to create “dopes” that 
can be used to create fibers, films, gels and foams. HFIP has been widely used and 
accepted as it is the only solvent that: 1) dissolves rSSPs at high concentrations (30% 
w/v) providing uniformity between various groups teting data; 2) is sufficiently volatile 
and miscible to be removed rapidly from the forming fiber; and 3) leaves little to no 
residue behind that could interfere with fiber formation. In addition, rSSPs generally are 
insoluble in aqueous solutions after purification, necessitating an organic solvent that 
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meets the criteria outlined in points 1 through 3. However, there are significant problems 
with solvating rSSPs in HFIP or other organic solvents. 
[0035] Dissolving rSSP in HFIP and then using pressure to ex rude the dope into a 
coagulation bath does not allow the appropriate structu es to form (notably β-sheets) to 
an extent that the fibers or films have to be post-spin processed multiple times to achieve 
protein structures that result in appreciable mechani al properties. For reference 
purposes, Lazaris et al. discuss Spider Silk Fibers Spun from Soluble Recombinant Silk 
Produced in Mammalian Cells, Science 295, 472-476 (2002) (herein after“Lazaris”); and 
Teule et al., Modifications of spider silk sequences in an attempt to control the 
mechanical properties of the synthetic fibers, J. Mater Sci, 42, 8974-8985 (2007) (herein 
after “Teule”). 
[0036] Such fiber processing methodologies include extruding the fiber into a 
coagulation bath that may include pure isopropanol or a mixture of isopropanol: water. 
The fiber may then be stretched (1.5 to 6 times) in a second bath generally containing a 
mixture of isopropanol and water. A third bath may also be employed that contains pure 
water or a majority of water, and a second stretch applied in that bath (Lazaris). Water is 
the recurrent theme in these baths and it is the wat r that converts the helical structures 
present due to HFIP into strength providing β-sheets (“Teule”). 
[0037] The cost of purchase and subsequent disposal of HFIP may be restrictive or 
prohibitive in an industrial setting of mass production. The cost to purchase HFIP is 
approximately $1,000/100mls of HFIP and 100ml of HFIP would likely be capable of 
solvating 20-30g of rSSP (20-30% w/v). Water is inexpensive even in its purest form. 
Referencing the MSDS published on Sigma Aldrich’s web-site, disposal of HFIP 
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requires; “Dissolve or mix the material with a combustible solvent and burn in a chemical 
incinerator equipped with an afterburner and scrubber,” a process that inherently has 
costs associated with it. Excess water can be evaporated or recycled and reused. Worker 
safety when utilizing such harsh, volatile solvents is also a consideration. 
[0038] Further referring to the MSDS; “Material is extremely destructive to tissue of the 
mucous membranes and upper respiratory tract, eyes, and skin. Cough, Shortness of 
breath, Headache, Nausea” (SIC). Water has no such requirements. Finally, the process 
of producing rSSP products could not be considered “green” using HFIP. rSSPs are 
largely insoluble in water. There are a few notable exceptions:Teule describes a series of 
proteins (Y1S8 and A2S8) that were produced in bacteria and purified via Ni++ 
chromatography. Short fibers were pulled straight from the eluted, pure rSSP fraction. 
Lazaris describes ADF-3 (Araneus diadematus MaSp1) produced in mammalian cell 
culture. Water soluble ADF- 3 was concentrated in the presence of glycine and extruded 
into a coagulation bath. A final example is a series of recombinant aciniform-like 
synthetic proteins that were able to be spun from an aqueous solution very similar to 
Teule 2007 (Xu 2012). Reference can be made to Xu et al., Recombinant Minimalist 
Spider Wrapping Silk Proteins Capable of Native-Like Fiber Formation. PloS-One 7(11): 
e50227. Doi: 10.1371/journal.pone.0050227 (2012). However, outside of this small sub-
set of rSSPs, water solubility is elusive. Noteworthy is that the majority of these proteins 
were much smaller than the natural proteins and thus are unlikely to make mechanically 
useful fibers. 
[0039] United States Patent Application Publication No. 2011/ 230911, published 
September 22, 2011, utilizes a top down approach using genetic manipulations and 
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expression system manipulations to try and create wr soluble silk proteins. 
Unfortunately, such processes are costly both in time to create the manipulations/cell 
lines and also the proteins appear to be expressed in mammalian cell cultures. The culture 
conditions for such cell lines are not only personnel and time intensive, but also the 
ingredients and equipment required are substantially more expensive than the more 
traditional bacterial expression systems. In addition, such methods are limiting as there 
are not that many iterations of various spider silk repeats that can be expressed in this 
manner that will result in a water soluble protein having appreciable mechanical 
properties. 
[0040] To address these and other challenges, this discusson sets forth new and novel 
methods for solubilizing rSSPs in aqueous solutions and then creating resulting spider 
silk compositions therefrom. The methods and composition  described herein in 
embodiments create aqueous dopes from rSSPs that are otherwise not soluble in water. 
The methods and compositions described herein may be pplied to proteins expressed by 
any organism, reducing the cost of production and also possibly improving the 
mechanical properties of the fibers, films, gels and foams by the inclusion of water in the 
dope. 
[0041] In certain embodiments, methods of preparing aqueous d pes of rSSP may 
include the following steps: mixing rSSP, water, and optional additives; optionally 





[0042] rSSP and water are combined to create a doping mixture of greater than about 2% 
w/v (e.g. 0.02g SSpS : 1 mL H2O). In embodiments, the w/v does not typically exceed 
50%. However, any percentage of less than 50% may be used. Suitable rSSPs include: 
MaSp1 (as described in United States Patent Nos. 7,521,228 and 5,989,894), MaSp2 (as 
described in United States Patent Nos. 7,521,228 and 5,989,894), MiSp1 (as described in 
United States Patent Nos. 5,733,771 and 5,756,677), MiSp2 (as described in United 
States Patent Nos.5,733,771 and 5,756,677), Flagelliform (as described in United States 
Patent No. 5,994,099), chimeric rSSPs (as described in United States Patent No. 
7,723,109), Pyriform, aciniform, tubuliform, aggregate gland silk proteins, and AdF-3 
and AdF-4 from Araneus diadematus. Each of the above referenced patents is herein 
incorporated by reference in its entirety. Dope Additives 
[0043] Various additives may be optionally added to the mixture. Suitable additives 
include compositions that contribute to the solubility of the rSSP in the solution. Some 
additives break or weaken disulfide bonds, thereby increasing the solubility of rSSPs. 
Other additives also serve to prevent hydrogel formation after the completion of the 
microwave step, as set forth below. If the solution f rms a hydrogel quickly and the 
desired end product is not a gel, then additives capable of delaying or inhibiting such a 
formation may be desirable. In some embodiments, multiple additives may be added to 
achieve desired end products. 
[0044] For example, to combat hydrogel formation, various additives may be added to 
the suspension of rSSP and water prior to microwaving the suspension. In some 
embodiments, acid, base, free amino acids, surfactants, or combinations thereof may be 
employed to combat hydrogel formation. For example, additions of acid (formic acid and 
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acetic acid alone or together at 0.1% to 10% v/v), base (ammonium hydroxide at 0.1% to 
10% v/v), free amino acids (L-Arginine and L-Glutamic Acid at 1 to 100mM) as well as 
a variety of surfactants (Triton X-100 at 0.1% v/v) may be used. The additions of these 
various chemicals not only aid the solubility of rSSP when microwaved but in certain 
combinations also delay the solution from turning ito a hydrogel long enough for the 
solution to be spun into a fiber.  
[0045] By altering and adjusting the combinations of additives to the dopes, the 
mechanical properties of the spun fiber are significantly iM Pacted. For example, too 
much acid or base may result in fibers that are brittle with little to no extensibility; too 
little acid or base may result in dopes where the rSSP will not solubilize to the extent 
necessary for fiber spinning or turns to a hydrogel quickly 
[0046] Exemplary additives also include compositions capable of breaking or weakening 
disulfide bonds, such as β-mercaptoethanol or dithiothreitol may be added to reduce 
bonds and increase solubility. Suitable amounts of such additives may include from about 
0.1 to about 5% (v/v). In embodiments where the rSSP does not contain cysteine, the use 
of such additives may be unnecessary. In some embodi ents employing major ampulate 
silk proteins 1 and 2 (MaSp1 and MaSp2, respectfully), disulfide bonds (cysteine) are 
present in the C-terminus of the non-repetitive regions of MaSp1 and MaSp2. These 
proteins are described in United States Patent Numbers 7,521,228 and 5,989,894, the 
entirety of both being herein incorporated by refernce. In addition, the C-term is present 
in various goat-derived spider silk proteins M4, M5and M55 proteins, which are 
described in United States Patent No. 7,157,615, issued January 2, 2007, the entirety of 
which is incorporated by reference in its entirety. In some embodiments, formic acid 
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and/or acetic acid may be included in as little as 0.3% (v/v) but even lower amounts 
(0.1% v/v) are possible. Additionally, it is possible to solubilize rSSP without using any 
additives. Exemplary additives are set forth in Table 1 (below), where dope formulations 
prepared according to the methods described herein and their resultant fibers/films 
mechanical properties are listed. 
Table B-1: Additives 
1 2 3 4 5 


















 Histidine  Calcium 
Other Organic 
Acids 
 Glycine  Potassium 
  Imadizole  Other 
Surfactants 




 Other Ions 
 
 [0047] To formulate an aqueous solution of rSSP, additives can be chosen from any of 
the five columns. For instance one or a combination of acids can be chosen from column 
one and combined with one or combinations of free amino acids from column three, as 
well as disulphide reducing compounds from column four and “Other” additives as 
required by the particular protein. Generally, it would not be useful to include both an 
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acid from column one with a base from column two. Hwever, a base from column two 
can be combined with additives from columns three and four.  
Sonication 
[0048] In some embodiments, the mixture containing water, rSSPs, and optional additives 
may be sonicated. The addition of sonication to the rSSP and water suspension may 
greatly increase the amount of solubilized protein. Sonication may be performed with any 
suitable sonicator, such as a Misonix 3000 with microt p at 3.0 watts) either prior to 
microwaving, after microwaving and cooling, or both. 
[0049] In embodiments, sonication may be employed to improve the amount of rSSP 
solubilized and, thus, reduce the amount of protein r quired to form an aqueous spin 
dope. Sonication also has the added benefit of producing a more homogenous solution. 
Sonication also improves and/or changes mechanical properties for rSSP composition 
products, particularly fiber mechanical properties.  
[0050] For example, initial experiments required a 12.5% w/v MaSp1 analogue (125 mg 
MaSp1 into 1ml of aqueous) in order to spin a fiber. Sonicating after microwaving 
reduced the concentration of MaSp1 to 5% w/v necessary to form fibers. Lower rSSP 
concentrations results in more fiber spun from a given amount of protein as well as finer 
fibers which has been demonstrated to increase the mechanical properties in other 
systems (electrospinning from HFIP based dope solutions (Teule).  
Microwaving 
[0051] The mixture containing water, rSSPs, and optional additives may be microwaved 
prior to or after the optional sonication step. In embodiments, any microwave may be 
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employed. In some embodiments, the mixture should be sealed prior to microwaving so 
as to avoid evaporation. 
[0052] The mixture may be microwaved for any suitable amount f time to achieve the 
desired end product. The time depends on the power f the microwave and the amount of 
solution to be microwaved. In some embodiments, the solution may be stirred or agitated 
during microwaving so as to evenly expose the mixture o the microwaves. Appropriate 
times per unit being microwaved include, for example, from 10 to 90 seconds per 1 
milliliter of mixture. In some embodiments the 1ml ixture may be set at from about 
10% to 100% power for from about 5 second to 120 seconds. 
[0053] After microwaving, the solution is allowed to cool and/or is taken to other 
processing steps, depending on the desired product. 
Centrifugation 
[0054] In some embodiments, the microwaved mixture may be optionally centrifuged. 
After 
centrifugation, the resulting supernatant may be removed and then used for rSSP 
compositions and further processing. 
Gel Formation 
[0055] Hydrogels may be generated from aqueous rSSP solutions by allowing the 
solubilized rSSP to cool. Additives to the dope such as acetic or formic acid can delay the 
formation of the hydrogel to allow the rSSP to be transferred to a mold prior to gelation. 
Theoretically, the variety of shapes that can be generated is limitless. The additives to the 
solution will change the mechanical properties of the resulting hydrogel. Hydrogel 
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formation has been observed in solutions with as little as 3% w/v rSSP:water and all 
iterations greater. 
[0056] The higher the percentage of rSSP, the more rapidly the solution gelates. Work in 
other systems, Bombyx mori silk, has proven the phenomenon that increasing the ratio of 
silk to water improves the mechanical characteristics of the resulting hydrogel. As well, 
altering the temperature, pH and including calcium ons changes the properties of the gels 
(Kim, UJ et al., 2004, Biomacromolecules “Structure and Properties of Silk Hydrogels” 
Biomacromolecules 5, 786- 792). 
[0057] An example of a hydrogel application is illustrated in Chao et al., “Silk Hydrogel 
for Cartilage Tissue Engineering.” Journal of Biomedical Materials Research Part B: 
Applied Biomaterials, Vol 95B, Issue 1 pg 84-90, 2010. 
[0058] Aerogels may be formed by freezing and then lyopholizing a solution or hydrogel 
of rSSP. 
Theoretically, the shapes for these aerogels is also limitless as their starting hydrogels 
could be allowed to form in a mold and then frozen and lyophilized. 
Film Formation 
[0059] Films may be produced by pouring a dope solution onto a substrate and allowing 
the water and other additives to evaporate. If it is desirable to remove the film from the 
substrate, PDMS or Teflon allow the removal of the films. A representative dope solution 
comprises 50 mg/ml MaSP1 analogue, 1% formic acid, 1% acetic acid. Films may be 
applied as coatings or utilized after removal from a substrate. Film formation will be 




[0060] Foam may be generated from aqueous based solvents by a variety of methods and 
dope 
conditions. One method reduced to practice is to formulate a dope solution 
similar/identical to that 
described for film generation. That solution is then placed into a vacuum chamber and a 
vacuum applied. The solution quickly expands and forms afoam upon curing in the 
chamber. Additives to the dopes such as surfactants will influence final cell size and 
further treatment of the foam (alcohol) are possible to also change the final properties of 
the foams. It is also possible that foams can be gen rated by chemical means, mainly 
peroxidase reactions, to produce CO2 that creates bubbles in the dope and upon curing a 
foam remains. As discussed in United States Patent Publication No. 20110230911, 
published on September 22, 2011, Scheibel. This method is also influenced by additives 
such as surfactants and post formation treatments (alcohol). A final method is an 
extrusion method whereby the dope solution is mechani ally mixed with air, or other gas, 
to produce foam. This method is also subject to additives and post formation treatments 
to alter the final foam product. 
Fiber Formation 
[0061] Fibers can be spun from aqueous solutions of rSSP by extrusion into a coagulation 
bath (alcohol) in a similar fashion as HFIP/aqueous ba ed solutions of rSSP as described 
in United States Patent Application Publication No.2005/0054830, published on March 
10, 2005. To summarize, the solubilized rSSP can be loaded into a syringe or other 
suitable extrusion instrument and then pushed through a fine bore needle into a bath 
comprised of isopropanol or other alcohol. As the rSSP drops through the alcohol, water 
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is removed and a fiber is formed. That fiber can then be taken up or processed further by 
stretching in a second or even third bath comprised of alcohol(s), alcohol(s) and water or 
just water. Fibers have been formed from solutions with as little as 5% w/v solutions of 
rSSP:water. Similar 5% w/v solutions using HFIP as the solvent will not form fibers. 
[0062] In some embodiments, it is not necessary for the solution to remain liquid to form 
fibers. Indeed, in some embodiments, fibers may be formed from a hydrogel. For 
example, when forming fibers from MaSp2 proteins, the process may be stopped, the 
syringe immediately removed for visualization, and  hydrogel may be observed. In 
contrast, forming fibers from a hydrogel with MaSp1 proteins results in deleterious 
effects. 
[0063] It is important to note that each individual rSSP, due to its unique amino acid 
sequence, will have different requirements for aqueous solubility. The rSSP 
concentration, microwave time and power setting, amount of acid or base, and 
requirements for free amino acids or surfactants will be different. There does not appear 
to be one set of additives that achieves aqueous sol bility and that also delays hydrogel 
formation for all rSSPs. 
[0064] As an example, a 12.5% w/v solution of a MaSp1 and MaSp2 analogue can be 
prepared 
identically in terms of additives. The MaSp1 will become soluble in water easily and stay 
liquid for an extended period of time. The MaSp2, on the other hand, will form a 
hydrogel within minutes of removal from the microwave and requires more microwave 
time to solubilize. 
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[0065] All examples in this document are illustrative only and are not intended to limit 
the disclosure in any way. 
Process Example - Dope Preparation: 
[0066] An aqueous recombinant spider silk protein (rSSP) dope solution was prepared by 
weighing out the rSSP such that a mass concentration of between 1 and 40% (w/v) of 
protein was achieved in 1 ml of water. For example, 50mg of protein in 1 ml of water 
yielded a 5% w/v solution of protein to water. The suspension of rSSP and water was 
sealed inside a 3 ml glass Wheaton vial using a PTFE lined cap. The suspension and vial 
were then placed in a conventional 1500 watt microwave and microwaved at 50% power 
for 30 seconds. This solubilized the protein powder in the water.  
[0067] Although this method may work to solubilize the rSSP, the solution quickly 
formed a hydrogel upon cooling and was generally not available thereafter to spin fibers 
by extrusion. If the goal of generating the aqueous dope is to form films, foams, 
hydrogels or aerogels, this method may be acceptable. Microwave time may vary 
depending on the volume of the dope, rSSP used, additives chosen, and whether 
sonication is utilized. 
Process Example-Sonication: 
[0068] The following samples were prepared, one of which was not sonicated: 
 Dope not sonicated (12.5% M4, 1% Acetic Acid, 1% formic acid, 50mM L-Arg, 
Microwaved 
30 seconds at 50% power, centrifuged at 6000 rpm for 3 minutes, 1.5X stretch, 40X 
objective); 
 Dope sonicated (5% M4, 1% acetic acid, 1% formic ac d, 50 mM L-Arg, microwaved 
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 35 seconds at 50% power, sonicated at power level 1.5 (3 Watts) for 1.5 min., 
microwaved 30 seconds at 50% power, centrifuged 1 min. at 6000 rpm, 1.5X stretch, 40X 
objective. 
 [0069] Fibers spun from dopes that are not sonicated (Figure 1A), when analyzed 
microscopically, appear to have numerous lumps and discontinuities. The sonicated 5% 
w/v MaSP1 fibers (Figure 1B) appear much more uniform. Sonication has the added 
benefit of requiring lower rSSP concentrations (5% coM Pared to greater than 8% 
without sonication) to spin fibers from lower concetrations are advantageous as less 
protein is used to spin similar lengths of fiber.  
[0070] Thus, fiber defects when spun from aqueous dopes may be diminished by 
sonication of the dope. 
[0071] The following examples set forth numerous rSSP sample tests and resulting data 
according the formulations and processing criteria set forth below: 
Example Set 1: 
25 mg of M5 (Nephila clavipes MaSP2 analogue) was measured out using a fine balance 
into a 3 ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in the dope 
solution: 
 50 uL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
 50 uL of glacial Acetic Acid (5% v/v) 
 900 uL of 18.2 MOhm water. 
[0072] The PTFE sealed cap was placed on the 3 ml vial tightly. The solution and vial 
were placed into a conventional microwave (GE 1.6kW) and microwaved for 30 seconds 
at 50% power. After microwaving, the solution was placed into a centrifuge (VWR 
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Clinical 2000 set at 6,000 RPM) for 2 minutes to clarify. The supernatant is removed 
from any remaining pellet for spinning fibers or producing other materials such as films, 
gels or foams. Fiber testing results (10 samples) for 1.5X post spin stretch in an 80:20 
isopropanol:water bath. Fiber testing results (9 samples) for 2.0X post spin stretch in an 
80:20 isopropanol:water bath. Diameter (µm) Energy to break (MJm-3) Max Stress (M 
Pa) Max Strain (mmmm-1) Average 37.40 1.98 52.94 0.0 7 
Standard deviation 2.27 1.43 0.03  
[0073] Fiber testing results (9 samples) for 2.5X post spin tretch in an 80:20 
isopropanol:water bath. 
 Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 37.25 0.75 60.05 0.02 Standard deviation2.95 0.25 9.11 0.003 Diameter (µm) 
 Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1)  
Average 38.91 18.07 41.64 0.68 
Standard deviation 5.15 14.64 17.17 0.54  
[0074] Fiber testing results (10 samples) for 3.0X post spin tretch in an 80:20 
isopropanol:water bath. 
[0075] Fiber testing results (10 samples) for 3.5X post spin tretch in an 80:20 
isopropanol:water bath. 
Example Set 2: 
125 mg of M5 (Nephila clavipes MaSP2 analogue) was measured out using a fine 
balance into a 3 ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in 
the dope solution: 
 50 µL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
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 100 µL of glacial Acetic Acid (10% v/v) 
 850 µL of 18.2 MOhm water. 
[0076] The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial 
were placed into a conventional microwave and microwaved for 30 seconds at 50% 
power. After microwaving, the solution was placed into a centrifuge (VWR Clinical 2000 
set at 6,000 RPM ) for 2 minutes to clarify. The supernatant was removed from any 
remaining pellet for spinning fibers or producing other materials such as films, gels or 
foams. 
[0077] Fiber testing results (9 samples) 1.5X post spin stretch in an 80:20 
isopropanol:water bath. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 26.71 40.25 84.54 0.57 
Standard deviation 2.12 14.27 18.04 0.18 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 23.07 22.73 106.65 0.25 
Standard deviation2.64 8.76 22.91 0.09 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 34.17 4.52 72.88 0.07 
Standard deviation 5.74 3.10 13.83 0.05 






[0079] Fiber testing results (10 samples) 2.5X post spin stretch in an 80:20 
isopropanol:water bath. 
[0080] Fiber testing results (10 samples) 3.0X post spin stretch in an 80:20 
isopropanol:water bath. 
Example Set 3: 
125 mg of M5 (Nephila clavipes MaSP2 analogue) was measured out using a fine 
balance into a 3ml 
Wheaton glass vial with PTFE seal inside a plastic cap. 
Included in the dope solution: 
 50 µL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
 150 µL of glacial Acetic Acid (15% v/v) 
 800 µL of 18.2 MOhm water. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 31.02 3.92 74.05 0.08 
Standard deviation 5.03 2.56 20.69 0.06 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 25.95 15.34 102.62 0.19 
Standard deviation 1.08 13.71 17.87 0.18 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 25.71 41.89 87.67 0.55 
Standard deviation 2.46 26.92 18.06 0.30 
[0081] The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial 
were placed into a conventional microwave and microwaved for 30 seconds at 50% 
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power. After microwaving, the solution was placed into a centrifuge (VWR Clinical 2000 
set at 6,000 RPM) for 2 minutes to clarify. The supernatant was removed from any 
remaining pellet for spinning fibers or producing other materials such as films, gels or 
foams. 
[0082] Fiber testing results (10 samples) 1.5X post spin stretch in an 80:20 
isopropanol:water bath. 
[0083] Fiber testing results (10 samples) 2.0X post spin stretch in an 80:20 
isopropanol:water bath. 
[0084] Fiber testing results (10 samples) 2.5X post spin stretch in an 80:20 
isopropanol:water bath. 
Example Set 4: 
125 mg of M5 (Nephila clavipes MaSP2 analogue) was measured out using a fine 
balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in the 
dope solution: 
 50 µL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
 200 µL of glacial acetic acid (20% v/v) 
 750 µL of 18.2 MOhm water. 
[0085] The PTFE sealed cap was placed on the 3 ml vial tightly. The solution and vial 
were placed into a conventional microwave and microwaved for 30 seconds at 50% 
power. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 39.20 3.77 69.92 0.07 
Standard deviation 10.74 3.66 15.36 0.06 
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Diameter (µm) Energy to break MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 46.93 20.47 53.81 0.37 
Standard deviation 5.23 23.18 14.17 0.35 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 46.05 24.95 52.00 0.49 
Standard deviation6.42 25.25 16.49 0.43 
[0086] After microwaving, the solution was placed into a centrifuge (VWR Clinical 2000 
set at 6,000 RPM) for 2 minutes to clarify. The supernatant was removed from any 
remaining pellet for spinning fibers or producing other materials such as films, gels or 
foams. 
[0087] Fiber testing results (10 samples) 1.5X post spin stretch in an 80:20 
isopropanol:water bath. 
[0088] Fiber testing results (9 samples) 2.0X post spin stretch in an 80:20 
isopropanol:water bath. 
[0089] Fiber testing results (10 samples) 3.5X post spin stretch in an 80:20 
isopropanol:water bath. 
Example Set 5: 
125 mg of M4 (Nephila clavipes MaSP1 analogue) was measured out using a fine 
balance into a 3 ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in 
the dope solution: 
 50 µL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
 10 µL of glacial acetic acid (1% v/v) 
 10 µL of 88% Formic acid (1% v/v) 
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 830 µL of 18.2 MOhm water. 
 [0090] The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial 
were placed into a conventional microwave and microwaved for 30 seconds at 50% 
power. After microwaving, the solution was placed into a centrifuge for 5 minutes to 
clarify. The supernatant was removed from any remaining pellet for spinning fibers or 
producing other materials such as films, gels or foams.  
 Diameter (µm) Energy to break (MJm-3) Max 
Stress (M Pa) Max Strain (mmmm-1). 
Average 46.38 0.26 33.18 0.014 
Standard deviation 10.11 0.11 7.64 0.003 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 44.65 1.09 63.71 0.02 
Standard deviation 8.29 1.39 32.07 0.009 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 37.44 8.44 80.85 0.13 
Standard deviation 2.04 11.70 8.09 0.16 
 [0091] Fiber testing results (10 samples) 1.5X post spin stretch in an 80:20 isopropanol: 
water bath. 
[0092] Fiber testing results (10 samples) 2.0X post spin stretch in an 80:20 isopropanol: 
water bath. 




[0094] Fiber testing results (9 samples) 3.0X post spin stretch in an 80:20 isopropanol: 
water bath. 
Example Set 6: 
125 mg of M4 (Nephila clavipes MaSP1 analogue) was measured out using a fine 
balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in the 
dope solution: 
 50 µL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
 10 µL of glacial acetic acid (1% v/v) 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 43.25 2.25 31.68 0.08 
Standard deviation 16.23 1.25 7.83 0.04 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 30.02 5.02 61.68 0.09 
Standard deviation 2.71 4.79 15.99 0.07 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 28.44 20.93 73.15 0.30 
Standard deviation 3.40 18.50 30.78 0.16 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 27.57 3.85 33.38 0.14 
Standard deviation 3.88 3.49 21.80 0.08 
 30 µL of 88% formic acid (3% v/v) 
 810 µL of 18.2 MOhm water. 
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[0095] The PTFE sealed cap was placed on the 3 ml vial tightly. The solution and vial 
were placed into a conventional microwave and microwaved for 30 seconds The solution 
and vial were allowed to cool and then, the solution was sonicated using a microtip on a 
Misonix sonicator for 1 minute at a power setting of 1.5. The PTFE sealed cap was 
placed on the 3ml vial tightly. The solution and vial were placed into a conventional 
microwave and microwaved for 30 seconds at 50% power. After microwaving, the 
solution was placed into a centrifuge for 5 minutes to clarify. The supernatant was 
removed from any remaining pellet for spinning fibers or producing other materials such 
as films, gels or foams.  
[0095] Fiber testing results (8 samples) 1.5X post spin stretch in an 80:20 
isopropanol:water bath. 
[0096] Fiber testing results (9 samples) 2.0X post spin stretch in an 80:20 
isopropanol:water bath. 
[0097] Fiber testing results (10 samples) 2.5X post spin stretch in an 80:20 
isopropanol:water bath. 
[0098] Fiber testing results (10 samples) 3.0X post spin stretch in an 80:20 
isopropanol:water bath. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 37.05 0.44 58.36 0.01 
Standard deviation 3.32 0.14 13.03 0.002 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 49.03 0.51 33.61 0.02 
Standard deviation 2.45 0.16 3.24 0.006 
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Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 39.26 2.43 65.19 0.05 
Standard deviation 10.08 1.96 35.24 0.04 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 26.42 1.12 98.28 0.02 
Standard deviation 2.27 0.19 13.89 0.002 
Example Set 7: 
50 mg (5% w/v) of M4 (Nephila clavipes MaSP1 analogue) was measured out using a 
fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap. Included 
in the dope solution: 
 50 µL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
 10 µL of glacial acetic acid (1% v/v) 
 940 µL of 18.2 MOhm water. 
[0099] The PTFE sealed cap was placed on the 3 ml vial tightly. The solution and vial 
were placed into a conventional microwave and microwaved for 30 seconds at 50% 
power. After microwaving and cooling for 5 minutes, the solution was sonicated for 1 
minute at 3.0 watts. After microwaving, the solution was placed into a centrifuge for 2 
minutes to clarify. The supernatant was removed from any remaining pellet for spinning 
fibers or producing other materials such as films, gels or foams. 
[0100] Fiber testing results 1.5X post spin stretch in an 80:20 isopropanol:water bath. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 26.35 0.74 59.87 0.02 
Standard deviation 0.35 0.39 8.30 0.007 
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[0101] Fiber testing results 3.0X post spin stretch in an 80:20 isopropanol:water bath. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 17.30 16.31 112.10 0.16 
Standard deviation 1.15 12.92 16.81 0.12 
Example Set 8: 
80 mg (8% w/v) of M4 (Nephila clavipes MaSP1 analogue) in addition to 20mg (2% 
w/v) of M5 (Nephila clavipes MaSP2 analogue) was measured out using a fine balance 
into a 3 ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in the dope 
solution: 
 50 µL of 1M L-Arginine (L-Arginine is prepared in 18.2 MOhm water) 
 50 µL of glacial acetic acid (5% v/v) 
 940 µL of 18.2 MOhm water. 
 [0102] The PTFE sealed cap was placed on the 3 ml vial tightly. The solution and vial 
were placed into a conventional microwave and microwaved for 35 seconds at 50% 
power. After microwaving, the solution was placed into a centrifuge for 3 minutes to 
clarify. The supernatant was removed from any remaining pellet for spinning fibers or 
producing other materials such as films, gels or foams. 
[0103] Fiber testing results 2.0X post spin stretch in an 80:20 isopropanol: water bath.  
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 31.62 1.70 68.16 0.04 
Standard deviation 5.59 0.42 14.59 0.003 
[0104] Fiber testing results 2.5X post spin stretch in an 80:20 isopropanol: water bath. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
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Average 29.05 10.63 80.98 0.16 
Standard deviation 1.07 3.84 10.78 0.04 
[0105] Fiber testing results 3.0X post spin stretch in an 80:20 isopropanol: water bath. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 25.48 23.31 84.91 0.31 
Standard deviation 1.85 17.46 6.96 0.23 
[0106] Fiber testing results 3.5X post spin stretch in an 80:20 isopropanol: water bath. 
Diameter (µm) Energy to break (MJm-3) Max Stress (M Pa) Max Strain (mmmm-1) 
Average 27.60 14.92 79.61 0.21 
Energy to break 3.88 10.83 37.40 0.13 
[0107] The methods and compositions described herein may also be applied to other 
traditionally 
insoluble proteins. Exemplary proteins that may be us d in these methods include 
naturally occurring and synthetic proteins associated with protein misfolding diseases 
such as prions (CWD, BSE, vBSE, Creutzfeldt-Jakob), Alzheimer’s, and Parkinson’s. 
[0108] Additionally, synthetically produced G-protein couple receptors (GPCR) are 
difficult targets as they to suffer aqueous solubility ssues. Approximately 40% of drugs 
produced today are targeted at GPCRs. The methods described herein may also be 
applied to such GPCR. 
 [0109] Having the above as a background for possible rSSP synthesis, the discussion 
will now focus on the films incorporating the rSSP. 
[0110] Referring initially to the drawings depicting the app ratus used in generating the 
films, Figure 2 schematically illustrates the card for receiving the film to be tested. The 
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C-card, referenced in greater detail herein after, is generally denoted by numeral 10 and 
includes a top section 12, bottom section 14 and conecting section 16 to thus define a 
“C” shape with an open area 18. In use, a sample of film (not shown) is cut to 3.5 x 13 
mm and weighed to determine thickness. The film is then mounted on the C-card length 
wise using Loctite super glue (liquid). The prepared sample is then loaded on an MTS 
Synergie 100 using a 50N load cell, while clamping the top and bottom sides into the 
instrument and cutting the side so the only component tested is the film. The film is then 
tested running TestWorks 4 2001 at 5mm/min and data collection at 30 Hz. A suitable 
material of which the card may be made is plastic, as an example. 
[0111] Typical dimensions for the C-card 10 include an overall length of 19 mm, width 
of 9.5 mm with a depth of the open area being 6.5 mm and a height of 8mm. These 
dimensions are, of course exemplary and specific for the testing devices used. In the 
event that alternative testing devices are employed, then there would be a commensurate 
change in the dimensions noted above. 
[0112] Figure 3 illustrates an embodiment of the apparatus used for stretching the 
synthesized films. Numeral 20 globally references the device, which includes opposed 
support end members 22 and 24. A plurality of rod frame members 26, 28 and 30 extend 
between members 22 and 24 and are fixedly secured therein to define an open 
framework. A first 32 and second 34 receiving member ar  mounted on he frame rod 
members 26, 28 and 30 at least one of the receiving members 32 and/or 34 is movably 
mounted to the rod members 26, 28 and 30. 
[0113] A threaded member 36 is mounted between end members 22 and 24 and extends 
through receiving members 32 and 34. The threaded member 36 may be actuated by 
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manual or power assistance. In the embodiment depicted, a handle 38 is provided for 
manual actuation. Once rotated, at least one of the receiving members 22 and 24 moves 
either towards or away from the other depending on the direction of rotation of the handle 
38 and thus threaded member 36. 
[0114] Film samples 40 are shown mounted to the receiving members 22 and 24 and are 
mounted by suitable adhesive. The arrangement is effective to stretch a series of samples 
of film 40 consistently with equivalent force and simultaneously to ensure reproducibility 
in stretch results. Conveniently, owing to the portability of the arrangement 20, a sample 
loaded arrangement, such as that shown, may be immersed ntirely in a solvent or the 
film exposed only (discussed herein after regarding film synthesis). Note that an 
automated version of this can be easily constructed from commonly available parts. 
Film Synthesis 
[0115] Turning now to the synthesis of the films, each water based dope formed and used 
in the example where noted, contained between 1% and 15% protein to which water was 
added together with acids, crosslinking agents, antibiotics, nanoparticles and/or 
surfactants depending on the protein in order to maxi ize solubility, increase process 
ability, functionalize and/or customize mechanical properties. The dope was microwaved 
for a period of between 10 and 60 seconds in a sealed container optionally followed by 
multiple steps of sonication and further microwaving to liquefy the dope and solubilize 
all protein. This procedure can be applied to both goat and bacterially derived spider silk 
protein as well as spider silk protein from any other source. 
[0116] Each water based dope was made in a sealed, microwavable vial capable of 
holding between 3 and 10 times the volume being made to prevent explosions. The 
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solution contained between 1% and 15% or 10-150 mg/mL of recombinant spider silk 
protein to which was added water, acids, imidazole, crosslinking agents, antibiotics, 
nanoparticles and/or surfactants depending on the desired final product in order to 
maximize solubility, increase processability, functionalize and/or customize mechanical 
properties. 
[0117] Each dope contained between 80% and 100% water and thus is referred to as a 
water-based dope. The vial containing the dope was se led and microwaved for a period 
of between 10 and 60 seconds which optionally was followed by multiple steps of 
sonication and further microwaving to liquefy the dope and solubilize all protein. This 
procedure has been applied to both goat derived spider s lk protein and bacterial-derived 
protein. 
[0118] HFIP based dopes are also made in sealed vial but may be filled to the top. The 
vial with the HFIP based dope is set to mix overnight on a mini labroller. The solution 
contains 1% and 15% or 10-150 mg/mL protein to which is added HFIP, acids, 
crosslinking agents, antibiotics, nanoparticles and/or surfactants depending on the desired 
final product in order to maximize solubility, increase processability, functionalize and/or 
customize mechanical properties. Each dope contains between 80% and 100% HFIP and 
thus is called a HFIP-based dope. 
FILM SYNTHESIS EXAMPLES 
 [0118] Example I 
[0119] Water-based M4 (WBM4): 
[0120] 50 mg of goat generated M4 (MaSp1 in Nephila clavipes) powder was placed into 
a 3 mL 
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Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope solution was 
1mL Nanopure water from a Thermo Fisher brand Barnstead. The plastic lid was then 
tightened onto the vial in order to prevent leaking. The vial and contents were then 
microwaved in a 1.6kW GE household microwave oven for 1 minute. The dope solution 
was then poured, 200 µL a band, onto 4 bands of Sylgard 182 silicone elastomer 
Polydimethylsiloxane (PDMS) 5: 1 base: curing agent measuring 30 x 7 mm and allowed 
to dehydrate. After drying, the film was cut to 3.5 x 13 mm and weighed to determine 
thickness. The film was then mounted on the plastic C-card, discussed supra with respect 
to Figure 1, length wise using Loctite super glue (liquid). The sample was then loaded on 
an MTS Synergie 100 using a 50N load cell, while clamping the top and bottom sides 
into the instrument and cutting the side so the only component tested was the film. The 
film was then tested running TestWorks 4 2001 at 5mmmin-1 and data collection at 30 
Hz.  
Results: Energy to break (MJm-3): 0.52; Stress (M Pa): 56.44; Strain (mmmm-1): 0.02 
[0121] Example II 
[0122] 50 mg of M4 powder was placed into a 3 mL Wheaton glass vial with PTFE seal 
inside a plastic lid. Included in the dope solution was 999mL Nanopure water from a 
Thermo Fisher brand Barnstead; 1 µL Formic acid, ACS, 88%+ from Alfa Aesar and 1 
µL Glutaraldehyde (Added after centrifugation step). The plastic lid was then tightened 
onto vial to prevent leaking. The vial and contents were then microwaved in a 1.6kW GE 
household microwave oven for 30 seconds The solution was then sonicated for 1.5 
minutes at a power setting of 3W using a Misonix sonict r 3000 with a microtip. The vial 
and contents were then microwaved in a 1.6kW GE household microwave oven for 30 
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seconds. The solution was then sonicated for 1.5 minutes at a power setting of 3W using 
a Misonix sonictor 3000 with a microtip. The vial and contents were then microwaved in 
a 1.6kW GE household microwave oven for 30 seconds. The vial was then placed in a 
VWR 50mL centrifuge tube with a 2 Kimwipes at the bottom for cushion. The centrifuge 
tube and contents were then placed in a VWR Clinical 200 centrifuge with a balance tube 
on the other side and centrifuged for 1 minute at 6000 RPM. Glutaraldehyde was then 
added to the vial and gently shaken to form a homogeneous mixture. 
[0123] The dope solution was then poured with 200µL per band onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5:1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After the drying stage, the film was prepared and 
tested as noted in the previous examples. The X- ray diffraction pattern is shown in 
Figure 4. The pattern illustrates some beta sheet, but there is no orientation as noted by 
the uniform density around the ring. 
Results: Energy to break: 0. MJm-3; Stress: 65.91 M Pa; Strain (mmmm-1): 0.02 
[0124] Example III 
[0125] 50 mg of M4 powder was introduced into a 3 mL Wheaton glass vial with PTFE 
seal inside a plastic lid. Included in the dope soluti n was 999 mL Nanopure water from a 
Thermo Fisher brand Barnstead; 1 µL Formic acid, ACS, 88%+ from Alfa Aesar and 1 
µL Glutaraldehyde (Added after centrifugation step). The plastic lid was then tightened 
onto vial to prevent leaking. The vial and contents were then microwaved as previous 
examples have delineated. 
[0126] The solution was sonicated for 1.5 minutes at a power setting of 3W using a 
Misonix sonicator 3000 with a microtip. The vial and contents were then microwaved in 
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a 1.6kW GE household microwave oven for 30 seconds. The vial was then placed in a 
VWR 50mL centrifuge tube with a 2 Kimwipes at the bottom for cushion. The centrifuge 
tube and contents were then placed in a VWR Clinical 200 centrifuge with a balance tube 
on the other side and centrifuged for 1 minute at 6000 RPM. Glutaraldehyde was then 
added to the vial and gently shaken to form a homogeneous mixture.  
[0127] The dope solution was then poured with 200 µL per band, onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5: 1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After the drying stage, the film was cut in half, 
length wise and glued onto the stretching device ref renced in Figure 3 discussed supra 
using Loctite superglue (liquid). The device was then turned top side down, dipping the 
films into a solution of 50% Isopropanol and 50% water for 1 minute. The film was 
stretched from 8.5 to 29.75 mm (3.5X). After stretching, the films were dried with a 
Kimwipes. The stretching device was then turned top side down into warm (60⁰ C) water 
and left to soak for 1 minute. After soaking, the films were dried with a Kimwipes and 
cut off of the stretching device and 15 mm cut out of the middle of the film. The film was 
then mounted on the plastic C-card supra .The sample was then loaded on an MTS 
Synergi similar to the previous examples. 
Results: Energy to break (MJm-3): 42.4; Stress (M Pa): 280.27; Strain (mmmm-1): 0.21 
[0128] Example IV 
 [0129] 50 mg of M4 powder was introduced into a 3 mL Wheaton glass vial with PTFE 
seal inside a plastic lid. Included in the dope soluti n is 999mL Nanopure water from a 
Thermo Fisher brand Barnstead; 1 µL Formic acid, ACS, 88%+ from Alfa Aesar and 1 
µL Glutaraldehyde (Added after centrifugation step). The plastic lid was then tightened 
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onto vial to prevent leaking. The vial and contents were then microwaved in a 1.6kW GE 
household microwave oven for 45 seconds. The vial was then placed in a VWR 50mL 
centrifuge tube with a 2 Kimwipes at the bottom for cushion. The centrifuge tube and 
contents were then placed in a VWR Clinical 200 centrifuge with a balance tube on the 
other side and centrifuged for 1 minute at 6000 RPM. Glutaraldehyde was then added to 
the vial and gently shaken to form a homogeneous mixture. 
[0130] The dope solution was then poured with 200 µL per band, onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5: 1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After drying, the film was cut in half, length wise 
and glued onto the stretching device of Figure 2. The device was then turned top side 
down, dipping the films into a solution of 50% Isopr anol and 50% water for 1 minute. 
The stretching device was then rotated top side up and the films stretched. This procedure 
was repeated to include separate stretches, namely (i) 8.5 to 21.25 mm (2.5X); (ii) 8.5 to 
25.5 mm (3X) and (iii) 8.5 to 29.75 mm (3.5X). After stretching, the films were cut off of 
the stretching device and 15mm removed from the middle of the film. The film was then 
mounted on the plastic C-card in a similar manner to that established in earlier referenced 
examples. 
[0131] The sample was then loaded on an MTS Synergie as previously noted and tested 
the same way as that discussed from the previous examples. 
Results: 




3X Stretch: Energy to break (MJm-3): 10.47; Stress (M Pa): 91.53; Strain (mmmm-1): 
0.14 
3.5X Stretch: Energy to break (MJm-3): 42.52; Stress (M Pa): 165.9; Strain (mmmm-1): 
0.30 
[0132] Example V 
[0133] 50 mg of M4 powder was introduced into a 3 mL Wheaton glass vial with PTFE 
seal inside a plastic lid. Included in the dope soluti n was 999 mL Nanopure water from a 
Thermo Fisher brand Barnstead; 1 µL Formic acid, ACS, 88%+ from Alfa Aesar; 1 µL 
Glutaraldehyde (Added after centrifugation step) and 100 µL gold nanoparticles (20nm) 
from Ted Pella, Inc. (Added after centrifugation step). The plastic lid was then tightened 
onto vial to prevent leaking. The vial and contents were then microwaved in a 1.6kW GE 
household microwave oven for 30 seconds. The vial was then placed in a VWR 50 mL 
centrifuge tube with a 2 Kimwipes at the bottom for cushioning purposes. The centrifuge 
tube and contents were then placed in a VWR Clinical 200 centrifuge with a balance tube 
on the other side and centrifuged for 1 minute at 6000 RPM. Gold nanoparticles were 
added to the solution. Glutaraldehyde was then added to the vial and gently shaken to 
form a homogeneous mixture. 
[0134] The dope solution was then poured with 200 µL per band, onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5:1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After the drying stage, the film was cut in half, 
length wise and glued onto the stretching device in a similar manner to that disclosed in 
the previous examples. The device was then turned top side down, dipping the films into 
a solution of 50% Isopropanol and 50% water for 1 minute. The film was stretched from 
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8.5 to 29.75 mm (3.5X). After stretching, the stretching apparatus was turned right side 
up and the films dried with a Kimwipe. The films were then treated with steam in place 
for 5 minutes. 
[0135] After steaming, the stretching apparatus was slackened from 29.75 to 28.5. The 
films were then dried with a Kimwipe and cut off the stretching device with 15mm 
removed from the middle of the film. The film was then mounted on the plastic C-card as 
discussed previously. 
[0136] The sample was then loaded on an MTS Synergie as noted previously. 
Results: Energy to break (MJm-3): 7.51; Stress (M Pa): 116.74; Strain (mmmm1): 0.08 
[0137] Example VI 
[0138] 50 mg of goat produced M4 (MaSp1 in Nephila clavipes) powder was introduced 
into a 3 mL Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope 
solution was 999mL Nanopure water from a Thermo Fisher brand Barnstead; 1 µL 
Formic acid, ACS, 88%+ from Alfa Aesar and 1 µL Kanamycin stock (15 mg/ml) 
(Added after centrifugation step). The plastic lid was then tightened onto vial to prevent 
leaking. The vial and contents were then microwaved in a 1.6kW GE household 
microwave oven for 30 seconds. 
[0139] The dope solution was then poured with 200 µL a band onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5:1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After drying, 7 mm discs were punched out of the 
films. The disc was then put onto a lawn of E. coli grown on LB agar. The result is 
illustrated in Figure 5. 
[0140] Example VII 
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 [0141] Water Based M5 (WBM5) 
[0142] 50 mg of goat produced M5 (MaSp2 in Nephila clavipes) powder was placed into 
a 3mL Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope 
solution was 850 µL Nanopure water from a Thermo Fisher brand Barnstead; 50 µL 
Acetic acid and 100 µL 50M L-Arginine . The plastic lid was then tightened onto vial to 
prevent leaking. The vial and contents were then microwaved in a 1.6kW GE household 
microwave oven for 15 seconds. The centrifuge tube and contents were then placed in a 
VWR Clinical 200 centrifuge with a balance tube on the other side and centrifuged for 1 
minute at 4185g. 
[0143] The dope solution was then poured with 200 µL per band, onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5:1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After drying, the film is cut to 3.5 x 13 mm and 
weighed to determine thickness. The film was then mounted on the plastic C-card as 
noted previously. 
[0144] The sample was then loaded on an MTS Synergie following similar parameters as 
above. The X-ray diffraction data is shown in Figure 6. The patterns illustrates that the 
film has increased beta sheet relative to X-Ray diffraction from Example II.  
Results: Energy to break (MJm-3): 0.67; Stress (M Pa): 41.60; Strain (mmmm1): 0.03 
[0145] Example VIII 
[0146] 40 mg of goat produced M5 (MaSp2 in Nephila clavipes) powder was introduced 
into a 3mL Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope 
solution was 800 µL Nanopure water from a Thermo Fisher brand Barnstead; 0.5 µL 
Formic acid; 200 µL 1M Imidazole and 0.5 µL Glutaraldehyde (Added after 
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centrifugation step). The plastic lid was then tightened onto vial to prevent leaking. The 
vial and contents are then microwaved in a 1.6kW GE household microwave oven for 30 
seconds. The centrifuge tube and contents were then placed in a VWR Clinical 200 
centrifuge with a balance tube on the other side and ce trifuged for 1 minute at 4185g. 
[0147] The dope solution was then poured with 200 µL per band, onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5:1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After the drying stage, the film was cut to 3.5 x 13 
mm and weighed to determine thickness. The film was then mounted on the plastic C-
card and tested as noted previously. 
[0150] Example IX 
 [0151] Water Based A4S8 
[0152] 50 mg of E. coli produced A4S8 (derived from MaSp2 and Flagelliform in 
Nephila clavipes) powder into a 3 mL Wheaton glass vial with PTFE seal inside a plastic 
lid. Included in the dope solution was 1mL Nanopure water from a Thermo Fisher brand 
Barnstead and 1 µL Formic acid, ACS, 88%+ from Alfa Aesar. The plastic lid was then 
tightened onto vial to prevent leaking. The vial and contents were then microwaved in a 
1.6kW GE household microwave oven for 15 seconds. 
[0153] The solution was then sonicated for 1.5 minutes at a power setting of 3W using a 
Misonix sonictor 3000 with a microtip. The vial and contents were then microwaved in a 
1.6kW GE household microwave oven for 15 seconds. The solution was then sonicated 
for 1.5 minutes at a power setting of 3W using a Mison x sonictor 3000 with a microtip. 
The vial and contents were then microwaved in a 1.6kW GE household microwave oven 
for 20 seconds. The vial was then placed in a VWR 50 mL centrifuge tube with a 2 
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Kimwipes at the bottom for cushion. The centrifuge tube and contents were then placed 
in a VWR Clinical 200 centrifuge with a balance tube on the other side and centrifuged 
for 3 minutes at 4185g.  
[0154] The dope solution was then poured with 400 µL per band, onto 4 bands of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5: 1 base: curing agent measuring 
30 x 7 mm and allowed to dehydrate. After the drying stage, the film was cut to 3.5 x 13 
mm and weighed to determine thickness. The film was then mounted on the plastic C-
card and tested as previously disclosed.  
Results: Energy to break (MJm-3): 0.27; Stress (M Pa): 41.37; Strain (mmmm-1): 0.01 
[0155] Example X- HFIP based M4 
[0156] 50 mg of goat produced M4 (MaSp1 in Nephila clavipes) powder was introduced 
into a 3mL Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope 
solution is 1mL HFIP. The plastic lid was then tighened onto vial to prevent leaking. The 
vial and contents were then mixed overnight on a mini labroller. 
[0157] The dope solution was then poured, 200 µL a well, into 4 wells of Sylgard 182 
silicone elastomer Polydimethylsiloxane (PDMS) mold using 5:1 base: curing agent 
measuring 30 x 7 x 0.3 mm and allowed to dehydrate. Aft r the drying stage, the film was 
cut to 3.5 x 13 mm and weighed to determine thickness. The film was on the plastic C-
card and tested as previously noted.  
Results: Energy to break (MJm-3): 1.07; Stress (M Pa): 40.85; Strain (mmmm-1): 0.05 
[0158] Example XI 
 [0159] 50 mg of goat produced M4 (derived from MaSp1 in Nephila clavipes) powder 
was introduced into a 3mL Wheaton glass vial with PTFE seal inside a plastic lid. 
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Included in the dope solution was 800 µL HFIP and 200 µL Formic acid, ACS, 88%+ 
from Alfa Aesar. The plastic lid was then tightened onto vial to prevent leaking. The vial 
and contents were then mixed overnight on a mini labroller. 
[0160] The dope solution was then poured with 200 µL per well, into 4 wells of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) mold using 5:1 base: curing agent 
measuring 30 x 7 x 0.3 mm and allowed to dehydrate. Aft r the drying stage, the film was 
cut to 3.5 x 13 mm and weighed to determine thickness. The film was then mounted on 
the plastic C- card and tested as previously discussed. 
[0161] The X- ray diffraction pattern is shown in Figure 7. The results of this X-Ray 
diffraction pattern are similar to those indicated with respect to Example II. 
Results: Energy to break (MJm-3): 2.87; Stress (M Pa): 50.4; Strain (mmmm-1): 0.08 
[0162] Example XII 
[0163] 50 mg of M4 (MaSp1 in Nephila clavipes) powder was introduced into a 3 mL 
Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope solution was 
1 mL HFIP and 1 µL Glutaraldehyde (Added 10 minutes before pouring flms). The 
plastic lid was then tightened onto vial to prevent l aking. The vial and contents were 
then mixed overnight on a mini labroller. Gluteraldehyde was added to the vial and 
gently shaken to homogenize the solution. 
[0164] The dope solution was then poured with 200 µL per well, into 4 wells of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) mold using 5:1 base: curing agent 
measuring 30 x 7 x 0.3 mm and allowed to dehydrate. Aft r the drying stage, the film was 
cut to 3.5 x 13 mm and weighed to determine thickness. The film was then mounted on 
the plastic C-card and tested as previously discussed. 
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[0165] The X- ray diffraction pattern is shown in Figure 8. This pattern shows both an 
increase beta sheet content and orientation as the density is higher than that in Examples 
II, VII and XI. The density is highly central to the equator which shows the sheets are 
oriented in the direction of the stretch of the film. Orientation factor 0.624 evinces this. 
Results: Energy to break (MJm-3): 21.12; Stress (M Pa): 17.35; Strain (mmmm-1): 1.638 
[0166] Example XIII 
 [0167] 50 mg of goat produced M4 (MaSp1 in Nephila clavipes) powder was introduced 
into a 3 mL Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope 
solution was 1 mL HFIP and 1 µL Glutaraldehyde (Added 10 minutes before pouring 
films). The plastic lid was then tightened onto vial to prevent leaking. The vial and 
contents were then mixed overnight on a mini labrolle . Gluteraldehyde was added to the 
vial and gently shaken to homogenize solution. 
[0168] The dope solution was then poured with 200 µL per well, into 4 wells of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5:1 base: curing agent measuring 
30 x 7 x 0.3 mm and allowed to dehydrate. After the drying stage, the excess was cut off 
the edges and the film cut in half, length wise andglued onto the stretching device as set 
forth previously. 
[0169] The device was then turned top side down, dipping the films into a solution of 
80% Methanol and 20% water for 30 seconds. The stretching device was then rotated top 
side up and the films stretched. This procedure was repeated to include separate stretches, 
namely (i) 8.5 to 17 mm (2X); (ii) 8.5 to 21.25 mm (2.5X) and (iii) 8.5 to 23.375 mm 
(2.75X). After stretching, the films were cut off o the stretching device and 15 mm 
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removed from the middle of the film. The film was then mounted on the plastic C-card 
and tested as previously discussed. 
[0170] The X- ray diffraction pattern is shown in Figure 9. The pattern shown is quite 
similar to that of Examples II, VII and XI. 
Results: 
2X Stretch: Energy to break (MJm-3): 36.72; Stress (M Pa): 115.55; Strain (mmmm-1): 
0.37 
2.5X Stretch: Energy to break (MJm-3): 39.39; Stress (M Pa): 189.18; Strain (mmmm-1): 
0.26 
2.75X Stretch: Energy to break (MJm-3): 52.33; Stress (M Pa): 212.46; Strain (mmmm-
1): 0.32 
[0171] Example XIV 
[0172] 50 mg of M5 (MaSp2 in Nephila clavipes) powder was introduced into a 3 mL 
Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope solution was 
1 mL HFIP and 1 µL Glutaraldehyde (Added 10 minutes before pouring flms). The 
plastic lid was then tightened onto vial to prevent l aking. The vial and contents were 
then mixed overnight on a mini labroller. Gluteraldehyde was added to the vial and 
gently shaken to homogenize the solution. 
[0173] The dope solution was then poured, 200 µL a well, into 4 wells of Sylgard 182 
silicone elastomer Polydimethylsiloxane (PDMS) mold using 5:1 base: curing agent 
measuring 30 x 7 x 0.3 mm and allowed to dehydrate. Aft r the drying stage, the film was 
cut to 3.5 x 13 mm and weighed to determine thickness. The film was then mounted on 
the plastic C-card and tested as previously discussed.  
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[0174] The X- ray diffraction pattern is shown in Figure 10. A similar pattern is 
demonstrated as provided for in Example XII which shows orientation of the beta sheets 
parallel to the direction of the stretch. The orientation factor of 0.447 indicates this, but, it 
is less than in Example XII. 
Results: Energy to break (MJm-3): 1.84; Stress (M Pa): 31.26; Strain (mmmm-1): 0.08 
[0175] Example XV 
[0176] 50 mg of goat produced M5 (MaSp2 in Nephila clavipes) powder was introduced 
into a 3 mL Wheaton glass vial with PTFE seal inside a plastic lid. Included in the dope 
solution was 1 mL HFIP and 1 µL Glutaraldehyde (Added 10 minutes before pouring 
films). The plastic lid was then tightened onto vial to prevent leaking. The vial and 
contents are then mixed overnight on a mini labrolle . Gluteraldehyde was added to the 
vial and gently shaken to homogenize the solution. 
[0177] The dope solution was then poured with 200 µL per well, into 4 wells of Sylgard 
182 silicone elastomer Polydimethylsiloxane (PDMS) 5:1 base: curing agent measuring 
30 x 7 x 0.3 mm and allowed to dehydrate. After the drying stage, the excess was 
removed from the edges and the film cut in half, length wise and glued onto the 
stretching device of Figure 2. 
[0178] The device was then turned top side down, dipping the films into a solution of 
80% Methanol and 20% water for 30 seconds. The stretching device was then rotated top 
side up and the films stretched. This procedure was repeated to include separate stretches, 
namely (i) 8.5 to 21.25 mm (2.5X) and (ii) 8.5 to 23.375 mm (2.75X). After stretching, 
the films were cut off of the stretching device and 15 mm removed from the middle of the 




2.5X Stretch: Energy to break (MJm-3): 33.36; Stress (M Pa): 132.17; Strain (mmmm-1): 
0.33 
2.75X Stretch: Energy to break (MJm-3): 16; Stress (M Pa): 117.87; Strain (mmmm-1): 
0.17 
[0179] In conclusion, it can be seen that the protocol results in very significant increases 
in desirable mechanical properties in the film product completely capable of full 
integration into the vast industries discussed herein. As is further evident from the data 
presented herein, stretching of the films results in increased beta sheet with orientation in 
direction of the stretch. This attribute explains the substantial increase in the strength of 
the films. 
 [0180] Although the embodiments of the invention have been described above, it is 
limited thereto and it will be apparent to those skilled in the art that numerous 
modifications from part of the present invention insofar as they do not depart from the 
spirit, nature and scope of the described invention. 
 
WE CLAIM : 
1. A method of forming silk protein film comprising the steps of: 
a) providing a solution containing silk proteins in a quantity sufficient to form a firm 
dissolved or 
suspended in a suitable solvent; 




imidazole and its analogs benzimidazole, dihydroimidazole, pyrrole, oxazole, thiazole, 
pyrazole and triazoles, crosslinking agents, antibiotics, nanoparticles , surfactants and 
combinations thereof; 
c) exposing the solution to microwaves for a period sufficient to solubilize the protein; 
d) pouring the microwave treated solution onto a substrate; and 
e) drying said film. 
2. The method as set forth in claim 1, wherein saidolution contains at least 1% by 
weight silk protein. 
3. The method as set forth in claim 2, wherein saidolution contains at least 60% by 
weight silk protein. 
4. The method as set forth in claim 2, wherein saidolution contains between 1% and 
60% by weight silk protein. 
5. The method as set forth in claim 2, wherein saidolution contains between 1% and 
15% by weight silk protein. 
6. The method of claim 1, wherein said solution is a dope and contains at least 80% water 
by weight. 
7. The method of claim 1, wherein said silk protein is recombinant spider silk protein 
which is goat derived. 
8. The method of claim 1, wherein said silk protein is recombinant spider silk protein 
which is bacterially derived. 
9.. The method of claim 1, wherein said silk protein is recombinant spider silk protein 
which is plant derived. 
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10. The method of claim 1, wherein said substrate comprises a polydimethysiloxane ( 
PDMS ) substrate. 
11. The method of claim 1, further including the stp of sonicating said mixture 
subsequent to microwave treatment. 
12. The method of claim 11, further including the st p of treating the sonicated mixture to 
further microwave treatment. 
13. The method of claim 1, further including the stp of centifuging said mixture prior to 
pouring. 
14. The method of claim 13, further including the st p of homogenizing said mixture 
prior to pouring. 
15. The method of claim 14, wherein homogenization is effected by the addition of a 
crosslinking compound to said mixture. 
16. The method of claim 1, wherein drying comprises refrigeration drying. 
17. The method of claim 1, wherein drying comprises half sash fume hood drying. 
18. The method of claim 7, wherein said is recombinant spider silk protein is selected 
from the group consisting of MaSp 2, MaSp1, MaSp1 analogues, MaSp2 analogues, Flag 
and Flag analogues, MiSp and MiSp analogues, Piri and Piri analogs, Acin and Acin. 
19. The method of claim 1, wherein said solution further includes additives for 
suppressing gel formation in the solution. 
20. The method of claim 19, wherein said additives are selected from the group 
consisting of an acid, a base, free amino acids and combinations thereof. 
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21. The method of claim 19, wherein said additives are selected from the group 
consisting of formic acid, acetic acid, ammonium hydroxide, L-arginine, L-glutamic acid, 
beta mercaptoethanol, dithiothreitol and combinations thereof. 
22. A method of forming silk protein film comprising the steps of: 
a) providing a solution containing silk proteins in a quantity sufficient to form a film 
dissolved or suspended in a suitable solvent; 
b) mixing said solution with a compound selected from the group comprising 
hexafluoroisopropanol (HFIP), acids, imidazole and its analogs benzimidazole, 
dihydroimidazole, pyrrole, oxale, thiazole, pyrazole and triazoles, crosslinking agents, 
antibiotics, nanoparticles , surfactants and combinations thereof; 
c) mixing said solution for a period sufficient to s lubilize the protein; 
d) pouring the mixed solution onto a substrate; and 
e) drying said film. 
23. The method as set forth in claim 22, wherein sad olution contains at least 1% by 
weight silk protein. 
24. The method as set forth in claim 22, wherein sad olution contains at least 60% by 
weight silk protein. 
25. The method as set forth in claim 22, wherein sad olution contains between 1% and 
60% by weight silk protein. 
26. The method as set forth in claim 22, wherein sad olution contains between 1% and 
15% by weight silk protein. 
27. The method of claim 22, wherein said solution is a dope and contains at least 80% 
HFIP by weight. 
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28. The method of claim 22, wherein said silk protein is recombinant spider silk protein 
which is goat derived. 
29. The method of claim 22, wherein said silk protein is recombinant spider silk protein 
which is bacterially derived. 
30. The method of claim 22, wherein said silk protein is recombinant spider silk protein 
which is plant derived. 
31. The method of claim 22, wherein said substrate comprises a polydimethysiloxane 
(PDMS) substrate. 
32. The method of claim 22, further including the st p of homogenizing said mixture 
prior to pouring. 
33. The method as set forth in claim 22, wherein drying comprises refrigeration drying. 
34. The method as set forth in claim 22, wherein drying comprises half sash drying. 
35. The method of claim 28, wherein said protein is recombinant spider silk protein is 
selected from the group consisting of MaSp 2, MaSp1, MaSp1 analogues, MaSp2 
analogues, Flag and Flag analogues, MiSp and MiSp analogues, Piri and Piri analogs, 
Acin and Acin analogs. 
36. The method of claim 22, wherein said solution further includes additives for 
suppressing gel formation in the solution. 
37. The method of claim 35, wherein said additives are selected from the group 
consisting of an acid, a base, free amino acids and combinations thereof. 
38. The method of claim 35, wherein said additives are selected from the group 
consisting of formic acid, acetic acid, ammonium hydroxide, L-arginine, L-glutamic acid, 
beta mercaptoethanol, dithiothreitol and combinations thereof. 
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39. A film made in accordance with the method of claim 1. 
40. A film made in accordance with the method of claim 22. 
41. A method for modifying a mechanical property of a recombinant spider silk protein 
film, comprising: 
a) providing a film made in accordance with claim 1; 
b) providing an alcohol and water mixture; 
c) conditioning said film in a conditioning step including stretching said film when said 
film is either within said mixture or out of said mixture; and 
d) maintaining said film , when conditioned with said mixture, in said mixture for a 
period between 30 seconds and 10 minutes whereby a mechanical property of said film is 
modified relative to an unconditioned film. 
42. The method of claim 41, further including the st p of quantifying mechanical 
properties by testing said film. 
43. The method of claim 42, wherein said mechanical properties include stress, strain and 
toughness. 
44. The method of claim 41, wherein said alcohol and water mixture comprises 
isopropanol and water. 
45. The method of claim 41, wherein said alcohol and water mixture comprises methanol 
and water. 
46. The method of claim 44, wherein said alcohol and water are present in a ratio of 
between 4:1 and 1:1. 
47. The method of claim 41, further including the st p of drying conditioned film. 
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48. The method of claim 43, further including the st p of soaking dried conditioned film 
in a water bath at a temperature of room temperature. 
49. The method of claim 48, wherein said temperature is at least 60°C. 
50. The method of claim 48, further including the st p of drying said film exposed to said 
water bath. 
51. The method of claim 48, wherein exposure is for a period of 60 seconds. 
52. The method of claim 47, further including the st p of exposing dried conditioned film 
to steam. 
53. The method of claim 44, wherein said film is stretched at least 100% relative to its 
initial dimensions. 
54. The method of claim 43, wherein stress, strain and toughness quantities of 
conditioned film are increased relative to film not c nditioned. 
55. A film made in accordance with the method of claim 41. 
56. A film made in accordance with the method of claim 47. 
57. A film made in accordance with the method of claim 48. 
58. A film made in accordance with the method of 52. 
59. A film made in accordance with the method of claim 1 in combination with a 
substrate selected from the group consisting of a csmetic composition; a pharmaceutical 
or medical composition ,drug delivery system, artificial cell, contact lens coating, 
sustained-release drug delivery system, artificial skin graft; food composition; automotive 
part; aeronautic component; computer or data storage device, building material, textile, 




60. A film made in accordance with the method of claim 22 in combination with a 
substrate selected from the group consisting of a csmetic composition; a pharmaceutical 
or medical composition, drug delivery system, artificial cell, contact lens coating, 
sustained-release drug delivery system, artificial skin graft; food composition; automotive 
part; aeronautic component; computer or data storage device, building material, textile, 
filter material, membrane material, nanomaterial, electronic component and combinations 
thereof. 
61. A film made in accordance with the method of claim 41 in combination with a 
substrate selected from the group consisting of a csmetic composition; a pharmaceutical 
or medical composition, drug delivery system, artificial cell, contact lens coating, 
sustained-release drug delivery system, artificial skin graft; food composition; automotive 
part; aeronautic component; computer or data storage device, building material, textile, 
filter material, membrane material, nanomaterial, electronic component and combinations 
thereof. 
62. A film made in accordance with the method of claim 47 in combination with a 
substrate selected from the group consisting of a csmetic composition; a pharmaceutical 
or medical composition, drug delivery system, artificial cell, contact lens coating, 
sustained-release drug delivery system, artificial skin graft; food composition; automotive 
part; aeronautic component; computer or data storage device, building material, textile, 
filter material, membrane material, nanomaterial, electronic component and combinations 
thereof. 
63. A film made in accordance with the method of claim 48 in combination with a 
substrate selected from the group consisting of a csmetic composition; a pharmaceutical 
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or medical composition, drug delivery system, artificial cell, contact lens coating, 
sustained-release drug delivery system, artificial skin graft; food composition; automotive 
part; aeronautic component; computer or data storage device, building material, textile, 
filter material, membrane material, nanomaterial, electronic component and combinations 
thereof. 
64. A film made in accordance with the method of claim 52 in combination with a 
substrate selected from the group consisting of a csmetic composition; a pharmaceutical 
or medical composition, drug delivery system, artificial cell, contact lens coating, 
sustained-release drug delivery system, artificial skin graft; food composition; automotive 
part; aeronautic component; computer or data storage device, building material, textile, 
filter material, membrane material, nanomaterial, electronic component and combinations 
thereof. 
65. A method for modifying a mechanical property of a recombinant spider silk protein 
film, comprising: 
a) providing a film made in accordance with claim 22;
b) providing an alcohol and water mixture; 
c) conditioning said film in a conditioning step including stretching said film when said 
film is either within said mixture or out of said mixture; and 
d) maintaining said film , when conditioned with said mixture, in said mixture for a 
period between 
30 seconds and 10 minutes whereby a mechanical property of said film is modified 
relative to an unconditioned film. 
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66. The method of claim 65, further including the st p of quantifying mechanical 
properties by testing said film. 
67. The method of claim 65, wherein said mechanical properties include stress, strain and 
toughness. 
68. The method of claim 65, wherein said alcohol and water mixture comprises 
isopropanol and water. 
69. The method of claim 65, wherein said alcohol and water mixture comprises methanol 
and water. 
70. The method of claim 68, wherein said alcohol and water are present in a ratio of 
between 4:1 and 1:1. 
71. The method of claim 69, wherein said alcohol and water are present in a ratio of 
between 4:1 and 1:1. 
72. The method of claim 65, further including the st p of drying conditioned film. 
73. The method of claim 72, further including the st p of soaking dried conditioned film 
in a water bath at a temperature of room temperature. 
74. The method of claim 73, wherein said temperature is at least 60°C. 
75. The method of claim 74, further including the st p of drying said film exposed to said 
water bath. 
76. The method of claim 75, wherein exposure is for a period of 60 seconds. 
77. The method of claim 72, further including the st p of exposing dried conditioned film 
to steam. 
78. The method of claim 63, wherein said film is stretched between 100% and 350% 
relative to its initial dimensions. 
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79. The method of claim 63, wherein stress, strain and toughness quantities of 
conditioned film are increased relative to film not c nditioned. 
ABSTRACT 
Methods for forming useful films using recombinant spider silk protein are discussed. In 
one embodiment, the method involves dissolving silk protein in a sufficient quantity to 
form a film suspended in a solvent. The solution is then mixed with a compound selected 
from water, acids, imidazole and its analogs benzimidazole, dihydroimidazole, pyrrole, 
oxazole, thiazole, pyrazole and triazoles, crosslinking agents, antibiotics, nanoparticles, 
surfactants and combinations thereof. Solubility of the protein in the solution is affected 
by microwave exposure. Once solubilized the microwave treated solution is poured onto 
a suitable substrate and dried in order to result in the final film, the protein may be plant, 
mammal or bacterially derived. The film has widesprad use and can be combined with 
any one of a number of substrates, examples of which include: a cosmetic composition; a 
pharmaceutical or medical composition, drug delivery system, artificial cell, contact lens 
coating, sustained-release drug delivery system, artificial skin graft; food composition; 
automotive part; aeronautic component; computer or data storage device, building 
material, textile, filter material, membrane material, nanomaterial, electronic component 










































Materials and Methods 
Drug loading 
 Films were also tested for drug release using a modified version of the method 
used by Hardy et. al. 46 Water based dopes were made using 0.1% formic acid and 
gluteraldehyde and poured as described above, with the exception of films poured with 
methyl violet in the dope. The methyl violet dopes had 10mg/mL of methyl violet put 
into the dope after microwaving, after which the dope solution was centrifuged. 
Gluteraldehyde was then added before pouring as describ d above. Films that were 
loaded with methyl violet were put into a solution f 10mg/mL methyl violet in water for 
72 hours. All films were washed in 80/20 MeOH/water solution for 2 minutes to release 
excess dye. The films were then placed in 2mL of PBS solution. Another set of films 
were created with methyl violet dopes was put into 2mL of PBS solution with 1g/L 
protease XIV (Sigma), covered, and put into a 37°C incubator.  
Drug Release Measurements 
After incubation, films were placed in 2mL of PBS solution and the optical 
density was measured at 1, 2, 3, 4, 7, 9, 11, and 15 days. Absorbance was measured at 
290nm using a Beckman Coulter DU530 lifescience UV/Vis spectrophotometer. 
Cell growth and adhesion 
 For the “increasing formic acid” study, films were made from dopes using the 
methods described in the water based manuscript with the exception that the films were 
poured (500µL) into a well of a sterile polystyrene 6 well costar cell culture plate 
(Corning, Inc.) using aseptic technique and allowed to ry for 3 days in a closed laminar 
flow hood at room temperature. The film containing the tripeptide RGD was made with 
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0.5% formic acid and the water based dope preparation protocol was followed, but 10µL 
of a 49mg/mL RGD solution was added after microwaving. The water based collagen 
film was made using the same protocol as the MaSp1 films with 0.5% formic acid and 30 
seconds of microwaving; the control was an empty well. After the films were dry, they 
were washed with 1 mL DPBS. The films were then seeded with adherent CHO cells at 
approximately 3 x 105 cells/well and incubated for 3 days. 
Cell count and Viability 
 Cell count and viability were quantified using a ViCELL, cell viability analyzer 
(Beckman Coulter). Media was first discarded and cells were washed with PBS.  Five 
hundred µL of a 0.25% trypsin solution was added per well and cells were incubated at 
37°C until they became detached (2-5 minutes). Media supplemented with FBS was 
added to the wells to inactivate the trypsin and then a 1mL sample was used to count cells 
in the ViCELL. 
Results and Discussion 
Films were tested for drug release using a modified version of the method used by 
Hardy et. al. 46 Films were both loaded and infused with methyl vioet and absorbance 
was measured. From these preliminary results it is obvious that the loaded films have a 
large release in the first 7 days and eventually get to a semi-steady state. In contrast, the 
films that were infused with methyl violet reached a steady state by day 3 and did not 
have as high of a release in the first day. The results of this process can be used to 
establish a basic understanding of the way drugs will release out of a formed film, and, 
depending on the application, an infused or loaded film can be used. This experiment also 
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provided information that shows that films can carry d ugs over at least a period of 15 
days. Further research can be done to decrease the initial release and to maintain a longer 
release. 
 
 Preliminary testing was done on films for cell growth and adherence using 
increasing concentrations of formic acid in the dopes (0, 0.1, 0.5, 1, and 2%) and the 
addition of RGD compared against collagen. As shown in figure 2, the increasing formic 
acid concentration lowers cell viability, with the exception of 2% acid, although the cell 
viabilities on all of these films were just as good or better than what we started with. The 
addition of formic acid led to a decrease in cell count, although all of the films have 
statistically indifferent cell counts. The control in figure 2 had the highest cell count, but 
the same percentage of viable cells.  
Figure C-1: Graph of absorbance of methyl violet in as-poured films comparing 




 We also compared the standard water based films with water based films 
containing 1M of RGD added to the dope before pouring and water based collagen films 
(Figure 4-3 and 4-4). The cell viability and cell count results of this experiment are 
indicative that RGD decreased both cell count and viability. The water based MaSp1 film 
had a low cell count using the ViCELL compared to the collagen and control wells, 
although, upon further examination, the microscope images of each film before 
trypsinizing show that the films with RGD had the highest cell density, with the MaSp1 
film having the next highest density (Figure 4-4). These results lead us to believe that the 
cells have a high affinity for the surfaces of the MaSp1 films with and without RGD, 
making it so the cells are not able to detach with the protocols being used. A different 
protocol for achieving cell counts and viability will be needed.  
Figure C-2: Graph of cell count and viability comparing water based MaSp1 films 
with increased formic acid concentrations, the control being an empty cell. Bars 






 We have been able to create films with tunable mechani al properties that are 
non-toxic to and allow the attachment and growth of mammalian cells. These findings 
indicate that synthetic spider silk films have high potential in the medical research and 




Figure C-4: Images of CHO cells on various films (A) Control, (B) water based 
collagen, (C) MaSp1 + 0.5% FA with RGD, and (D) MaSp1 + 0.5% FA 
A B C D 
Figure C-3: Graph of cell count and viability comparing water based MaSp1 with 
MaSp1 with RGD and water based collagen, the control being an empty cell. Bars 
indicate mean and error bars indicate standard deviation. 
